| Date | KEGG | ATC | Active ingredient | Drug name | Company | Remark |
| 2024/12/20 | D11847 | B02BX10 | Concizumab | Alhemo | Novo Nordisk Inc | BLA |
| 2024/12/20 | D13024 | R07AX33 | Vanzacaftor, tezacaftor and deutivacaftor | Alyftrek | Vertex Pharmaceuticals Inc | NME |
| 2024/12/19 | D13023 | Olezarsen sodium | Tryngolza | Ionis Pharmaceuticals Inc | NME | |
| 2024/12/18 | D11356 | Ensartinib hydrochloride | Ensacove | Xcovery Holdings, Inc | NME | |
| 2024/12/13 | D12366 | Crinecerfont | Crenessity | Neurocrine Biosciences, Inc | NME | |
| 2024/12/13 | D11946 | Cosibelimab | Unloxcyt | Checkpoint Therapeutics, Inc | BLA | |
| 2024/12/4 | D11991 | Zenocutuzumab | Bizengri | Merus N.V. | BLA | |
| 2024/11/27 | D01719 | V08AB10 | Iomeprol | Iomervu | Bracco Diagnostics Inc | |
| 2024/11/22 | D01847 | C07AB14 | Landiolol hydrochloride | Rapiblyk | AOP Orphan Pharmaceuticals | NME |
| 2024/11/22 | D11973 | (C01EB25) | Acoramidis hydrochloride | Attruby | BridgeBio Pharma, | NME |
| 2024/11/20 | D12011 | (L01FD07) | Zanidatamab | Ziihera | Jazz Pharmaceuticals Ireland Limited | BLA |
| 2024/11/15 | D12729 | Revumenib citrate | Revuforj | Syndax Pharmaceuticals | NME | |
| 2024/10/25 | D12976 | Sulopenem etzadroxil and probenecid | Orlynvah | Iterum Therapeutics U.S. | NME | |
| 2024/10/18 | D11527 | (L01FX31) | Zolbetuximab | Vyloy | Astellas | BLA |
| 2024/10/11 | D11261 | (B02BX11) | Marstacimab | Hympavzi | Pfizer Inc | BLA |
| 2024/10/10 | D11942 | Inavolisib | Itovebi | Genentech, Inc | NME | |
| 2024/9/27 | D10009 | Flurpiridaz F 18 | Flyrcado | GE Healthcare Inc | NME | |
| 2024/9/26 | D12968 | Xanomeline and trospium chloride | Cobenfy | Bristol-Myers Squibb | NME | |
| 2024/9/24 | D12967 | Levacetylleucine | Aqneursa | IntraBio Inc | NME | |
| 2024/9/20 | D11493 | N07XX17 | Arimoclomol citrate | Miplyffa | Zevra Therapeutics | NME |
| 2024/9/13 | D09633 | D11AH10 | Lebrikizumab | Ebglyss | Eli Lilly | BLA |
| 2024/8/19 | D12245 | L01EB09 | Lazertinib mesylate hydrate | Lazcluze | Janssen Biotech | NME |
| 2024/8/14 | D11952 | (L04AG19) | Axatilimab | Niktimvo | Incyte Corporation | BLA |
| 2024/8/14 | D11257 | (A05AX07) | Seladelpar lysine | Livdelzi | Gilead Sciences | NME |
| 2024/8/12 | D11080 | D11AH12 | Nemolizumab | Nemluvio | Galderma Laboratories LP | BLA |
| 2024/8/9 | D12395 | H05AA05 | Yorvipath | Yorvipath | Ascendis Pharma Bone Diseases AS | NME |
| 2024/8/6 | D11835 | (L01XM04) | Vorasidenib citrate | Voranigo | Servier Pharmaceuticals | NME |
| 2024/7/25 | D11867 | Deuruxolitinib phosphate | Leqselvi | Sun Pharmaceutical Industries | NME | |
| 2024/7/2 | D11500 | N06DX05 | Donanemab | Kisunla | Eli Lilly | BLA |
| 2024/6/26 | D11743 | (R03BX02) | Ensifentrine | Ohtuvayre | Verona Pharma | NME |
| 2024/6/20 | D11696 | L04AJ07 | Crovalimab | Piasky | Genentech, Inc | BLA |
| 2024/6/18 | D10989 | (D11AA02) | Sofpironium bromide | Sofdra | Botanix SB Inc | BLA |
| 2024/6/10 | D11208 | A05AX06 | Elafibranor | Iqirvo | Ipsen Pharmaceuticals | NME |
| 2024/6/6 | D09630 | L01XX80 | Imetelstat sodium | Rytelo | Geron | NME |
| 2024/5/16 | D12234 | (L01FX33) | Tarlatamab | Imdelltra | Amgen Inc | BLA |
| 2024/4/26 | D11510 | (L03AX24) | Mavorixafor | Xolremdi | X4 Pharmaceuticals | NME |
| 2024/4/23 | D12291 | (L01EC04) | Tovorafenib | Ojemda | Day One Biopharmaceuticals | NME |
| 2024/4/22 | D12888 | Nogapendekin alfa inbakicept | Anktiva | Altor Bioscience | BLA | |
| 2024/4/17 | D12887 | (V04CX13) | Pegulicianine acetate | Lumisight | Lumicell Inc | NME |
| 2024/4/3 | D08886 | J01DI01 | Ceftobiprole medocaril | Zevtera | Basilea Pharmaceutica | NME |
| 2024/3/29 | D11641 | L04AJ09 | Danicopan | Voydeya | AstraZeneca | NME |
| 2024/3/27 | D11078 | B03XA08 | Vadadustat | Vafseo | Akebia Therapeutics | NME |
| 2024/3/26 | D09670 | (C02KX06) | Sotatercept | Winrevair | Merck Sharp Dohme | BLA |
| 2024/3/21 | D12743 | M09AX14 | Givinostat hydrochloride | Duvyzat | Italfarmaco S.A | NME |
| 2024/3/19 | D11441 | C02KN01 | Aprocitentan | Tryvio | Idorsia Pharmaceuticals US Inc | NME |
| 2024/3/14 | D11602 | (A05BA11) | Resmetirom | Rezdiffra | Madrigal Pharmaceuticals | NME |
| 2024/3/13 | D11487 | L01FF09 | Tislelizumab | Tevimbra | BeiGene | BLA |
| 2024/2/29 | D10949 | Letibotulinumtoxin A | Letybo | Hugel Inc | BLA | |
| 2024/2/22 | D12818 | J01DE51 | Cefepime and enmetazobactam | Exblifep | Allecra Therapeutics | NME |
| 2024/1/5 | D12758 | (D06BB13) | Berdazimer sodium | Zelsuvmi | LNHC Inc | NME |
| 2023/12/21 | D12754 | N07XX21 | Eplontersen sodium | Wainua | AstraZeneca Pharmaceuticals LP | NME |
| 2023/12/18 | D12755 | Birch triterpens | Filsuvez | Lichtenheldt GmbH | NME | |
| 2023/12/5 | D12252 | L04AJ08 | Iptacopan hydrochloride | Fabhalta | Novartis Pharmaceuticals | NME |
| 2023/11/27 | D11453 | (L01XX81) | Nirogacestat hydrobromide | Ogsiveo | SpringWorks Therapeutics | NME |
| 2023/11/16 | D11371 | L01EX27 | Capivasertib | Truqap | AstraZeneca | NME |
| 2023/11/16 | D11986 | L03AA18 | Efbemalenograstim alfa | Ryzneuta | Evive Biotechnology Singapore | BLA |
| 2023/11/15 | D11454 | (L01EX28) | Repotrectinib | Augtyro | Bristol-Myers Squibb | NME |
| 2023/11/15 | D12737 | Taurolidine and heparin | Defencath | CorMedix Inc | ||
| 2023/11/8 | D11977 | L01EK04 | Fruquintinib | Fruzaqla | Takeda Pharmaceuticals America | NME |
| 2023/10/27 | D12202 | L01FF13 | Toripalimab | Loqtorzi | Coherus BioSciences | BLA |
| 2023/10/26 | D11123 | L04AC24 | Mirikizumab | Omvoh | Eli Lilly | BLA |
| 2023/10/26 | D11000 | H02AB18 | Vamorolone | Agamree | Santhera Pharmaceuticals | NME |
| 2023/10/17 | D11550 | L04AC21 | Bimekizumab | Bimzelx | UCB Inc | BLA |
| 2023/10/17 | D12356 | L04AJ06 | Zilucoplan sodium | Zilbrysq | UCB Inc | NME |
| 2023/10/12 | D10931 | L04AE05 | Etrasimod arginine | Velsipity | Pfizer Inc | NME |
| 2023/9/29 | D12723 | (A16AX25) | Nedosiran sodium | Rivfloza | Novo Nordisk | NME |
| 2023/9/28 | D11798 | A16AB23 | Cipaglucosidase alfa | Pombiliti | Amicus Therapeutics US | BLA |
| 2023/9/22 | D04314 | N06AX19 | Gepirone hydrochloride | Exxua | Fabre-Kramer Pharmaceuticals | NME |
| 2023/9/15 | D10889 | L01EJ04 | Momelotinib dihydrochloride monohydrate | Ojjaara | GlaxoSmithKline | NME |
| 2023/9/8 | D12282 | (L03AX23) | Motixafortide acetate | Aphexda | BioLineRx | NME |
| 2023/8/18 | D11477 | (L04AJ11) | Pozelimab | Veopoz | Regeneron Pharmaceuticals | BLA |
| 2023/8/16 | D09365 | M09AX11 | Palovarotene | Sohonos | Ipsen Biopharmaceuticals | NME |
| 2023/8/14 | D12058 | (L01FX32) | Elranatamab | Elrexfio | Pfizer Inc | BLA |
| 2023/8/9 | D12180 | L01FX29 | Talquetamab | Talvey | Janssen Biotech | BLA |
| 2023/8/4 | D11748 | (S01XA32) | Avacincaptad pegol sodium | Izervay | Iveric bio | NME |
| 2023/8/4 | D11793 | (N06AX31) | Zuranolone | Zurzuvae | Sage Therapeutics | NME |
| 2023/7/25 | D11212 | (S01AX25) | Lotilaner | Xdemvy | Tarsus Pharmaceuticals | NME |
| 2023/7/21 | D11745 | Cantharidin | Ycanth | Verrica Pharmaceuticals | NME | |
| 2023/7/20 | D09956 | L01EX11 | Quizartinib dihydrochloride | Vanflyta | Daiichi Sankyo | NME |
| 2023/7/17 | D11380 | J06BD08 | Nirsevimab | Beyfortus | AstraZeneca | BLA |
| 2023/6/27 | D10990 | H01AC08 | Somatrogon | Ngenla | Pfizer Inc | BLA |
| 2023/6/26 | D12182 | L04AG16 | Rozanolixizumab | Rystiggo | UCB Inc | BLA |
| 2023/6/23 | D11970 | L04AF08 | Ritlecitinib tosylate | Litfulo | Pfizer Inc | NME |
| 2023/6/15 | D11833 | L01FX28 | Glofitamab | Columvi | Genentech | BLA |
| 2023/5/26 | D10669 | A10BK06 | Sotagliflozin | Inpefa | Lexicon Pharmaceuticals | NME |
| 2023/5/25 | D12606 | (V09IX18) | Flotufolastat F18 gallium | Posluma | Blue Earth Diagnostics Ltd. | NME |
| 2023/5/23 | D12607 | J07BX05 | Respiratory syncytial virus vaccine, adjuvanted | Arexvy | GlaxoSmithKline Biologicals SA | BLA |
| 2023/5/23 | D12605 | Sulbactam and durlobactam | Xacduro | Entasis Therapeutics | NME | |
| 2023/5/19 | D12368 | L01FX27 | Epcoritamab | Epkinly | Genmab US | BLA |
| 2023/5/18 | D12604 | Perfluorohexyloctane | Miebo | Bausch & Lomb Americas | NME | |
| 2023/5/12 | D11976 | G02CX06 | Fezolinetant | Veozah | Astellas Pharma US, Inc | NME |
| 2023/5/9 | D11685 | A16AB20 | Pegunigalsidase alfa | Elfabrio | Chiesi Farmaceutici S.p.A. | BLA |
| 2023/4/25 | D11811 | N07XX22 | Tofersen | Qalsody | Biogen MA Inc | NME |
| 2023/3/24 | D11159 | L03AX22 | Leniolisib phosphate | Joenja | Pharming Technologies B.V. | NME |
| 2023/3/22 | D11198 | J02AX08 | Rezafungin acetate | Rezzayo | Cidara Therapeutics | NME |
| 2023/3/22 | D11827 | L01FF10 | Retifanlimab | Zynyz | Incyte Corporation | BLA |
| 2023/3/10 | D12400 | (N07XX24) | Trofinetide | Daybue | Acadia Pharmaceuticals | NME |
| 2023/3/9 | D11899 | (N02CD08) | Zavegepant hydrochloride | Zavzpret | Pfizer Inc | NME |
| 2023/2/28 | D10964 | (N07XX25) | Omaveloxolone | Skyclarys | Reata Pharmaceuticals | NME |
| 2023/2/17 | D11776 | (C09XX01) | Sparsentan | Filspari | Travere Therapeutics | NME |
| 2023/2/16 | D11024 | A16AB15 | Velmanase alfa | Lamzede | Chiesi Farmaceutici S.p.A. | BLA |
| 2023/2/1 | D10874 | B03XA07 | Daprodustat | Jesduvroq | GlaxoSmithKline | NME |
| 2023/1/27 | D11672 | L02BA04 | Elacestrant dihydrochloride | Orserdu | Stemline Therapeutics | NME |
| 2023/1/27 | D12050 | L01EL05 | Pirtobrutinib | Jaypirca | Eli Lilly | NME |
| 2023/1/20 | D10865 | A10BK08 | Bexagliflozin | Brenzavvy | TheracosBio | NME |
| 2023/1/6 | D11678 | N06DX04 | Lecanemab | Leqembi | Eisai | BLA |
| 2022/12/28 | D12495 | D03BA03 | Anacaulase | NexoBrid | MediWound | BLA |
| 2022/12/28 | D11243 | L04AG14 | Ublituximab | Briumvi | TG Therapeutics | BLA |
| 2022/12/23 | D12496 | (V04CX12) | Xenon Xe 129 hyperpolarized | Xenoview | Polarean | NME |
| 2022/12/22 | D11463 | L01FX25 | Mosunetuzumab | Lunsumio | Genentech | BLA |
| 2022/12/22 | D12162 | J05AX31 | Lenacapavir sodium | Sunlenca | Gilead Sciences | NME |
| 2022/12/12 | D12301 | L01XX77 | Adagrasib | Krazati | Mirati Therapeutics | NME |
| 2022/12/1 | D12483 | (L01XM03) | Olutasidenib | Rezlidhia | Forma Therapeutics | NME |
| 2022/11/18 | D09013 | A10XX01 | Teplizumab | Tzield | Provention Bio | BLA |
| 2022/11/14 | D10954 | L01FX26 | Mirvetuximab soravtansine | Elahere | ImmunoGen | BLA |
| 2022/10/25 | D12177 | L01FX24 | Teclistamab | Tecvayli | Janssen Biotech | BLA |
| 2022/10/21 | D06657 | L01FX20 | Tremelimumab | Imjudo | AstraZeneca Pharmaceuticals | BLA |
| 2022/9/30 | D11725 | L01EN04 | Futibatinib | Lytgobi | Taiho Oncology | NME |
| 2022/9/29 | D12439 | N07XX19 | Sodium phenylbutyrate and taurursodiol | Relyvrio | Amylyx Pharmaceuticals | |
| 2022/9/22 | D10966 | S01EX06 | Omidenepag isopropyl | Omlonti | Santen | NME |
| 2022/9/21 | D12435 | V08CA12 | Gadopiclenol | Elucirem | Guerbet | NME |
| 2022/9/14 | D08571 | H01BA04 | Terlipressin acetate | Terlivaz | Mallinckrodt Hospital Products | NME |
| 2022/9/9 | D11188 | L03AA19 | Eflapegrastim | Rolvedon | Spectrum Pharmaceuticals | BLA |
| 2022/9/9 | D11817 | L04AF07 | Deucravacitinib | Sotyktu | Bristol-Myers Squibb | NME |
| 2022/9/7 | D10921 | Daxibotulinumtoxin A | Daxxify | Revance Therapeutics | BLA | |
| 2022/9/1 | D12066 | L04AC22 | Spesolimab | Spevigo | Boehringer Ingelheim Pharmaceuticals | BLA |
| 2022/8/31 | D10820 | A16AB25 | Olipudase alfa | Xenpozyme | Genzyme | BLA |
| 2022/6/13 | D11916 | N07XX18 | Vutrisiran sodium | Amvuttra | Alnylam Pharmaceuticals | NME |
| 2022/5/23 | D11365 | D05AX07 | Tapinarof | Vtama | Dermavant Sciences | NME |
| 2022/5/13 | D11360 | A10BX16 | Tirzepatide | Mounjaro | Eli Lilly | BLA |
| 2022/5/3 | D10775 | A02BD14 | Vonoprazan, amoxicillin and clarithromycin | Voquenza | Phathom Pharmaceuticals | |
| 2022/4/28 | D12265 | C01EB24 | Mavacamten | Camzyos | MyoKardia, Inc | NME |
| 2022/4/26 | D11785 | J02AC06 | Oteseconazole | Vivjoa | Mycovia Pharmaceuticals | NME |
| 2022/3/23 | D12335 | V10XX05 | Lutetium Lu 177 vipivotide tetraxetan | Pluvicto | Novartis Pharmaceuticals | NME |
| 2022/3/18 | D12334 | L01FY02 | Nivolumab and relatlimab | Opdualag | Bristol-Myers Squibb | |
| 2022/3/18 | D04300 | N03AX27 | Ganaxolone | Ztalmy | Marinus Pharmaceuticals | NME |
| 2022/2/28 | D11768 | L01EJ03 | Pacritinib | Vonjo | CTI BioPharma Corp. | NME |
| 2022/2/17 | D11408 | B06AX04 | Mitapivat sulfate | Pyrukynd | Agios Pharmaceuticals | NME |
| 2022/2/11 | D12174 | Bebtelovimab | Bebtelovimab | Eli Lilly | EUA | |
| 2022/2/4 | D11530 | L04AJ04 | Sutimlimab | Enjaymo | Bioverativ USA | BLA |
| 2022/1/28 | D11516 | S01LA09 | Faricimab | Vabysmo | Genentech | BLA |
| 2022/1/25 | D12296 | L01XX75 | Tebentafusp | Kimmtrak | Immunocore | BLA |
| 2022/1/14 | D11400 | D11AH08 | Abrocitinib | Cibinqo | Pfizer Inc | NME |
| 2022/1/7 | D11887 | N05CJ03 | Daridorexant hydrochloride | Quviviq | Idorsia Pharmaceuticals US | NME |
| 2021/12/27 | D09979 | D11AH07 | Tralokinumab | Adbry | LEO Pharma | BLA |
| 2021/12/23 | D11943 | J05AB18 | Molnupiravir | Molnupiravir | Merck Sharp & Dohme Corp. | EUA |
| 2021/12/22 | D12269 | J05AE30 | Nirmatrelvir and ritonavir | Paxlovid | Pfizer Inc | EUA |
| 2021/12/22 | D12293 | C10AX16 | Inclisiran | Leqvio | Novartis AG | NME |
| 2021/12/17 | D11876 | L04AA58 | Efgartigimod alfa | Vyvgart | argenx BV | BLA |
| 2021/12/17 | D11771 | R03DX11 | Tezepelumab | Tezspire | AstraZeneca AB | BLA |
| 2021/12/8 | D12262 | J06BD03 | Tixagevimab and cilgavimab | Evusheld | AstraZeneca Pharmaceuticals | EUA |
| 2021/11/29 | D12250 | V04CX10 | Pafolacianine sodium | Cytalux | On Target Laboratories LLC | NME |
| 2021/11/23 | D04859 | J05AX10 | Maribavir | Livtencity | Takeda Pharmaceuticals USA | NME |
| 2021/11/19 | D11190 | M05BX07 | Vosoritide | Voxzogo | BioMarin Pharmaceutical Inc | BLA |
| 2021/11/12 | D11027 | L03AB15 | Ropeginterferon alfa-2b | Besremi | PharmaEssentia Corporation | BLA |
| 2021/10/29 | D11404 | L01EA06 | Asciminib hydrochloride | Scemblix | Novartis Pharmaceuticals | NME |
| 2021/10/7 | D11093 | L04AJ05 | Avacopan | Tavneos | ChemoCentryx, Inc | NME |
| 2021/9/29 | D10952 | A05AX04 | Maralixibat chloride | Livmaril | Mirum Pharmaceuticals | NME |
| 2021/9/28 | D11313 | N02CD07 | Atogepant | Qulipta | AbbVie | NME |
| 2021/9/20 | D11814 | L01FX23 | Tisotumab vedotin | Tivdak | Seagen | BLA |
| 2021/9/15 | D11969 | L01EB10 | Mobocertinib succinate | Exkivity | Takeda Pharmaceuticals America | NME |
| 2021/8/25 | D11486 | H01AC09 | Lonapegsomatropin | Skytrofa | Acendis Pharma Endocrinology Div A/S | BLA |
| 2021/8/23 | D11971 | J07BN01 | Tozinameran | Comirnaty | BioNTech Manufacturing GmbH | BLA |
| 2021/8/23 | D10890 | V03AX04 | Difelikefalin acetate | Korsuva | Cara Therapeutics Inc | NME |
| 2021/8/13 | D11954 | L01XX74 | Belzutifan | Welireg | Merck | NME |
| 2021/8/13 | D12206 | J07BA01 | Tick-borne encephalitis vaccine | Ticovac | Pfizer Ireland Pharmaceuticals | BLA |
| 2021/8/6 | D11744 | A16AB22 | Avalglucosidase alfa | Nexviazyme | Genzyme Corporation | BLA |
| 2021/7/30 | D11082 | L04AG11 | Anifrolumab | Saphnelo | AstraZeneca Pharmaceuticals | BLA |
| 2021/7/20 | D11716 | A05AX05 | Odevixibat | Bylvay | Albireo Pharma, Inc | NME |
| 2021/7/16 | D11816 | L04AA48 | Belumosudil mesylate | Rezurock | Kadmon Pharmaceuticals | NME |
| 2021/7/16 | D11252 | P01CA03 | Fexinidazole | Fexinidazole | Drugs for Neglected Diseases initiative | NME |
| 2021/7/16 | D12205 | J07AL02 | Pneumococcal 15-valent conjugate vaccine | Vaxneuvance | Merck Sharp & Dohme Corp. | BLA |
| 2021/7/9 | D10633 | C03DA05 | Finerenone | Kerendia | Bayer HealthCare Pharmaceuticals Inc | NME |
| 2021/6/30 | D02997 | L01XX02 | Asparaginase erwinia chrysanthemi | Rylaze | Jazz Pharmaceuticals Inc | |
| 2021/6/8 | D12207 | J07AL02 | Pneumococcal 20-valent conjugate vaccine | Prevnar 20 | Wyeth Pharmaceuticals | BLA |
| 2021/6/7 | D10541 | N06DX03 | Aducanumab | Aduhelm | Biogen Inc | BLA |
| 2021/6/1 | D11545 | J02AX07 | Ibrexafungerp citrate | Brexafemme | SCYNEXIS, Inc | NME |
| 2021/5/28 | D12117 | N05AH53 | Olanzapine and samidorphan | Lybalvi | Alkermes Inc | |
| 2021/5/28 | D11611 | L01EN03 | Infigratinib phosphate | Truseltiq | QED Therapeutics Inc | NME |
| 2021/5/28 | D12055 | L01XX73 | Sotorasib | Lumakras | Amgen Inc | NME |
| 2021/5/26 | D12014 | J06BD05 | Sotrovimab | Sotrovimab | GlaxoSmithKline LLC | BLA |
| 2021/5/26 | D12132 | V09IX16 | Piflufolastat F 18 | Pylarify | Progenics Pharmaceuticals Inc | NME |
| 2021/5/21 | D11894 | L01FX18 | Amivantamab | Rybrevant | Janssen Biotech | BLA |
| 2021/5/14 | D11613 | L04AJ03 | Pegcetacoplan | Empaveli | Apellis Pharmaceuticals Inc | NME |
| 2021/4/23 | D11338 | L01FX22 | Loncastuximab tesirine | Zynlonta | ADC Therapeutics SA | BLA |
| 2021/4/22 | D11366 | L01FF07 | Dostarlimab | Jemperli | GlaxoSmithKline | BLA |
| 2021/4/15 | D12047 | G03AA18 | Drospirenone and estetrol | Nextstellis | Mayne Pharma | |
| 2021/4/2 | D02572 | N06AX09 | Viloxazine hydrochloride | Qelbree | Supernus Pharmaceuticals | NME |
| 2021/3/22 | D12314 | H04AA02 | Dasiglucagon hydrochloride | Zegalogue | Zealand Pharma AS | NME |
| 2021/3/18 | D11215 | L04AE04 | Ponesimod | Ponvory | Janssen Pharmaceuticals Inc | NME |
| 2021/3/10 | D10190 | L01EK03 | Tivozanib hydrochloride | Fotivda | Aveo Pharmaceuticals | NME |
| 2021/3/3 | D11989 | N06BA15 | Serdexmethylphenidate and dexmethylphenidate | Azstarys | Commcave Therapeutics SA | |
| 2021/2/27 | D12129 | J07BN02 | COVID-19 vaccine (Ad26.COV2-S [recombinant]) | Janssen COVID-19 Vaccine | Janssen Biotech Inc | EUA |
| 2021/2/26 | D11870 | L01AA10 | Melphalan flufenamide hydrochloride | Pepaxto | Oncopeptides AB | NME |
| 2021/2/26 | D11780 | A16AX19 | Fosdenopterin hydrobromide | Nulibry | Origin Biosciences Inc | NME |
| 2021/2/25 | D11988 | M09AX13 | Casimersen | Amondys 45 | Sarepta Therapeutics Inc | NME |
| 2021/2/12 | D11987 | V03AF12 | Trilaciclib dihydrochloride | Cosela | G1 Therapeutics Inc | NME |
| 2021/2/11 | D11753 | C10AX17 | Evinacumab | Evkeeza | Fierce Pharma | BLA |
| 2021/2/5 | D11323 | L01EX25 | Umbralisib tosylate | Ukoniq | TG Therapeutics Inc | NME |
| 2021/2/3 | D11073 | L01EX21 | Tepotinib hydrochloride | Tepmetko | EMD Serono Inc | NME |
| 2021/1/22 | D09033 | L04AD03 | Voclosporin | Lupkynis | Aurinia Pharmaceuticals | NME |
| 2021/1/21 | D11966 | Cabotegravir and rilpivirine | Cabenuva | Viiv Healthcare | ||
| 2021/1/19 | D11051 | C01DX22 | Vericiguat | Verquvo | Merck Sharp Dohme | NME |
| 2020/12/23 | D10433 | G04BD15 | Vibegron | Gemtesa | Urovant Sciences Inc | NME |
| 2020/12/18 | D12114 | J07BN01 | COVID-19 mRNA vaccine (nucleoside-modified) | Moderna COVID-19 Vaccine | ModernaTX Inc | EUA |
| 2020/12/11 | D11971 | J07BN01 | COVID-19 mRNA vaccine (nucleoside-modified) | Pfizer-BioNTech COVID-19 Vaccine | Pfizer Inc | EUA |
| 2020/12/21 | D11875 | J06BD04 | Ansuvimab | Ebanga | Ridgeback Biotherapeutics | BLA |
| 2020/12/18 | D10888 | L02BX04 | Relugolix | Orgovyx | Myovant Sciences Inc | NME |
| 2020/12/16 | D10446 | L01FD06 | Margetuximab | Margenza | MacroGenics Inc | BLA |
| 2020/12/14 | D11691 | D06BX03 | Tirbanibulin | Klisyri | Almirall LLC | NME |
| 2020/12/3 | D11674 | B06AC06 | Berotralstat dihydrochloride | Orladeyo | BioCryst Pharmaceuticals | NME |
| 2020/12/1 | Gallium 68 PSMA-11 | Gallium 68 PSMA-11 | University of California | NME | ||
| 2020/11/25 | D11416 | L01FX21 | Naxitamab | Danyelza | Y-mabs Therapeutics | BLA |
| 2020/11/25 | D11928 | A08AA12 | Setmelanotide acetate | Imcivree | Rhythm Pharmaceuticals | NME |
| 2020/11/23 | D11926 | A16AX18 | Lumasiran sodium | Oxlumo | Alnylam Pharms | NME |
| 2020/11/21 | D12142 | J06BD07 | Casirivimab and imdevimab | Regen-cov | Regeneron Pharmaceuticals | |
| 2020/11/20 | D04768 | A16AX20 | Lonafarnib | Zokinvy | Eiger Biopharms | NME |
| 2020/10/22 | D11472 | J05AB16 | Remdesivir | Veklury | Gilead Sciences | NME |
| 2020/10/14 | D11922 | Atoltivimab, maftivimab and odesivimab | Inmazeb | Regeneron Pharmaceuticals | BLA | |
| 2020/9/4 | D11712 | L01EX23 | Pralsetinib | Gavreto | Blueprint Medicines | NME |
| 2020/9/3 | D11882 | V09IX15 | Copper Cu 64 dotatate | Detectnet | Radiomedix Inc | NME |
| 2020/8/28 | D11194 | H01AC07 | Somapacitan | Sogroya | Novo Nordisk Inc | BLA |
| 2020/8/26 | D11451 | D10AX06 | Clascoterone | Winlevi | Cassiopea | NME |
| 2020/8/14 | D11079 | L04AC19 | Satralizumab | Enspryng | Genentech | BLA |
| 2020/8/12 | D11528 | M09AX12 | Viltolarsen | Viltepso | NS Pharma | NME |
| 2020/8/7 | D11214 | N02AX07 | Oliceridine | Olinvyk | Trevena | NME |
| 2020/8/7 | D11406 | M09AX10 | Risdiplam | Evrysdi | Genentech | NME |
| 2020/8/6 | D00833 | P01CC01 | Nifurtimox | Lampit | Bayer Healthcare Pharmaceuticals | NME |
| 2020/8/5 | D11595 | L01FX15 | Belantamab mafodotin | Blenrep | GlaxoSmithKline | BLA |
| 2020/7/31 | D11601 | L01FX12 | Tafasitamab | Monjuvi | MorphoSys AG | BLA |
| 2020/7/24 | D10687 | P03AX07 | Abametapir | Xeglyze | Dr. Reddy's Laboratories | NME |
| 2020/7/7 | D11848 | L01BC58 | Decitabine and cedazuridine | Inqovi | Otsuka Pharmaceutical | |
| 2020/7/2 | D10708 | J05AX29 | Fostemsavir tromethamine | Rukobia | Viiv Healthcare | NME |
| 2020/7/2 | D10194 | N05CD14 | Remimazolam besylate | Byfavo | Cosmo Technologies | NME |
| 2020/6/30 | D11465 | A16AX17 | Triheptanoin | Dojolvi | Ultragenyx Pharmaceutical | NME |
| 2020/6/15 | D11644 | L01XX69 | Lurbinectedin | Zepzelca | Pharma Mar USA | NME |
| 2020/6/11 | D11757 | L04AG10 | Inebilizumab | Uplinza | Viela Bio | BLA |
| 2020/5/28 | D11210 | V09AX07 | Flortaucipir F 18 | Tauvid | Avid Radiopharmaceuticals | NME |
| 2020/5/26 | D02482 | P01BE03 | Artesunate | Artesunate | Amivas | NME |
| 2020/5/20 | D11829 | V09IX11 | Fluoroestradiol F18 | Cerianna | Zionexa | NME |
| 2020/5/15 | D11353 | L01EX19 | Ripretinib | Qinlock | Deciphera Pharmaceuticals | NME |
| 2020/5/8 | D11713 | L01EX22 | Selpercatinib | Retevmo | Loxo Oncology | NME |
| 2020/5/6 | D10891 | L01EX17 | Capmatinib hydrochloride | Tabrecta | Novartis Pharmaceuticals | NME |
| 2020/4/24 | D10825 | N04BX04 | Opicapone | Ongentys | Neurocrine Biosciences | NME |
| 2020/4/22 | D10985 | L01FX17 | Sacituzumab govitecan | Trodelvy | Immunomedics | BLA |
| 2020/4/17 | D11417 | L01EN02 | Pemigatinib | Pemazyre | Incyte | NME |
| 2020/4/17 | D11141 | L01EH03 | Tucatinib | Tukysa | Seattle Genetics | NME |
| 2020/4/10 | D10024 | L01EE04 | Selumetinib sulfate | Koselugo | AstraZeneca Pharmaceuticals | NME |
| 2020/3/25 | D10967 | L04AE02 | Ozanimod hydrochloride | Zeposia | Celgene | NME |
| 202/3/20 | D12923 | J07AP03 | Purified Vi polysaccharide typhoid vaccine | Typhim Vi | Sanofi Pasteur SA | BLA |
| 2020/3/6 | D11062 | H02CA02 | Osilodrostat phosphate | Isturisa | Novartis Pharmaceuticals | NME |
| 2020/3/2 | D11050 | L01FC02 | Isatuximab | Sarclisa | Sanofi Aventis US | BLA |
| 2020/2/27 | D10663 | N02CD06 | Rimegepant sulfate | Nurtec ODT | Biohaven Pharma | NME |
| 2020/2/26 | D07310 | N05AL05 | Amisulpride | Barhemsys | Acacia Pharma | NME |
| 2020/2/21 | D11303 | N02CD05 | Eptinezumab | Vyepti | Lundbeck Seattle BioPharmaceuticals | BLA |
| 2020/2/21 | D10691 | C10AX15 | Bempedoic acid | Nexletol | Esperion Therapeutics | NME |
| 2020/2/12 | D08266 | A06AD12 | Lactitol | Pizensy | Braintree Labs | |
| 2020/1/23 | D11485 | L01XX72 | Tazemetostat hydrobromide | Tazverik | Epizyme | NME |
| 2020/1/21 | D09680 | L04AG13 | Teprotumumab | Tepezza | Horizon Therapeutics | BLA |
| 2020/1/9 | D11279 | L01EX18 | Avapritinib | Ayvakit | Blueprint Medicines | NME |
| 2019/12/23 | D10673 | N02CD04 | Ubrogepant | Ubrelvy | Allergan | NME |
| 2019/12/20 | D11529 | L01FD04 | Trastuzumab deruxtecan | Enhertu | Daiichi Sankyo | BLA |
| 2019/12/20 | D11022 | N05CJ02 | Lemborexant | Dayvigo | Eisai | NME |
| 2019/12/20 | D11170 | N05AD10 | Lumateperone tosylate | Caplyta | Intra-cellular therapies | NME |
| 2019/12/20 | D10799 | Brilliant blue G | Tissueblue | Dutch Ophthalmic Research Center | NME | |
| 2019/12/18 | D11525 | L01FX13 | Enfortumab vedotin | Padcev | Astellas Pharma | BLA |
| 2019/12/12 | D11707 | M09AX08 | Golodirsen | Vyondys 53 | Sarepta Therapeutics | NME |
| 2019/11/25 | D11330 | B06AX03 | Voxelotor | Oxbryta | Global Blood Therapeutics | NME |
| 2019/11/21 | D11150 | N03AX25 | Cenobamate | Xcopri | SK Life Science | NME |
| 2019/11/20 | D11708 | A16AX16 | Givosiran sodium | Givlaari | Alnylam Pharmaceuticals | NME |
| 2019/11/15 | D11480 | B06AX01 | Crizanlizumab | Adakveo | Novartis Pharmaceuticals | BLA |
| 2019/11/14 | D11013 | J01DI04 | Cefiderocol sulfate tosylate | Fetroja | Shionogi | NME |
| 2019/11/14 | D11422 | L01EL03 | Zanubrutinib | Brukinsa | BeiGne | NME |
| 2019/11/8 | D11701 | B03XA06 | Luspatercept | Reblozyl | Celgene | BLA |
| 2019/10/21 | D11700 | R07AX32 | Elexacaftor, ivacaftor and tezacaftor | Trikafta | Vertex Pharmaceuticals | NME |
| 2019/10/11 | D10424 | N02CC08 | Lasmiditan succinate | Reyvow | Eli Lilly | NME |
| 2019/10/10 | D04220 | V09IX05 | Fluorodopa F 18 | Fluorodopa F 18 | Feinstein | NME |
| 2019/10/8 | D11334 | D02BB02 | Afamelanotide acetate | Scenesse | Clinuvel | NME |
| 2019/10/7 | D11083 | S01LA06 | Brolucizumab | Beovu | Novartis Pharmaceuticals | BLA |
| 2019/10/4 | D11225 | D10AD06 | Trifarotene | Aklief | Galderma Research and Development | NME |
| 2019/9/12 | D11653 | A06AX08 | Tenapanor hydrochloride | Ibsrela | Ardelyx | NME |
| 2019/8/27 | D04641 | N04CX01 | Istradefylline | Nourianz | Kyowa Kirin | NME |
| 2019/8/21 | D11651 | V09IX09 | Edotreotide gallium Ga-68 | Ga-68-dotatoc | Univ Iowa Hosps and Clinics Pet Imaging Center | NME |
| 2019/8/19 | D11632 | J01XX12 | Lefamulin | Xenleta | Nabriva Therapeutics | NME |
| 2019/8/16 | D11048 | L04AF03 | Upadacitinib hemihydrate | Rinvoq | AbbVie | NME |
| 2019/8/16 | D11296 | L01EJ02 | Fedratinib hydrochloride | Inrebic | Impact Biomedicines | NME |
| 2019/8/15 | D10926 | L01EX14 | Entrectinib | Rozlytrek | Genentech | NME |
| 2019/8/14 | D10722 | J04AK08 | Pretomanid | Pretomanid | Global Alliance for TB Drug Development | NME |
| 2019/8/2 | D11271 | L01EX15 | Pexidartinib hydrochloride | Turalio | Daiichi Sankyo | NME |
| 2019/7/30 | D11045 | L02BB06 | Darolutamide | Nubeqa | Bayer Healthcare Pharmaceuticals | NME |
| 2019/7/25 | D10833 | B03AB10 | Ferric maltol | Accrufer | Shield therapeutics | NME |
| 2019/7/16 | D11621 | J01DH56 | Imipenem, cilastatin and relebactam | Recarbrio | Merck | NME |
| 2019/7/3 | D11222 | L01XX66 | Selinexor | Xpovio | Karyopharm Therapeutics | NME |
| 2019/6/21 | D06569 | G02CX05 | Bremelanotide | Vyleesi | Amg Pharmaceuticals | NME |
| 2019/6/10 | D10761 | L01FX14 | Polatuzumab vedotin | Polivy | Genentech | BLA |
| 2019/5/24 | D11011 | L01EM03 | Alpelisib | Piqray | Novartis Pharmaceuticals | NME |
| 2019/5/3 | D09674 | N07XX08 | Tafamidis meglumine | Vyndaqel | FoldRx | NME |
| 2019/4/23 | D11052 | L04AC18 | Risankizumab | Skyrizi | AbbVie | BLA |
| 2019/4/12 | D10927 | L01EN01 | Erdafitinib | Balversa | Janssen Biotech | NME |
| 2019/4/9 | D10156 | M05BX06 | Romosozumab | Evenity | Amgen | BLA |
| 2019/3/26 | D11072 | L04AE03 | Siponimod fumarate | Mayzent | Novartis Pharmaceuticals | NME |
| 2019/3/20 | D11328 | N06BA14 | Solriamfetol hydrochloride | Sunosi | Jazz Pharmaceuticals | NME |
| 2019/3/19 | D11149 | N06AX29 | Brexanolone | Zulresso | Sage Therapeutics | NME |
| 2019/2/13 | D07364 | P02BX04 | Triclabendazole | Egaten | Novartis Pharmaceuticals | NME |
| 2019/2/6 | D11160 | B01AX07 | Caplacizumab | Cablivi | Ablynx | BLA |
| 2019/2/1 | D11405 | M03AX01 | Prabotulinumtoxin A | Jeuvea | Evolus | BLA |
| 2018/12/21 | D11054 | L04AJ02 | Ravulizumab | Ultomiris | Alexion Pharmaceuticals | BLA |
| 2018/12/21 | D11358 | L01XX67 | Tagraxofusp | Elzonris | Stemline Therapeutics | BLA |
| 2018/12/20 | D10096 | (L01XX86) | Calaspargase pegol | Asparlas | Servier Pharmaceuticals LLC | BLA |
| 2018/12/14 | D10152 | A06AX05 | Prucalopride succinate | Motegrity | Shire Development LLC | NME |
| 2018/11/28 | D10800 | L01EX13 | Gilteritinib fumarate | Xospata | Astellas Pharma | NME |
| 2018/11/26 | D11138 | L01EX12 | Larotrectinib sulfate | Vitrakvi | Loxo Oncology | NME |
| 2018/11/21 | D11107 | L01XJ03 | Glasdegib maleate | Daurismo | Pfizer | NME |
| 2018/11/20 | D11120 | L04AG09 | Emapalumab | Gamifant | Novimmune SA | BLA |
| 2018/11/16 | D08480 | A07AA13 | Rifamycin sodium | Aemcolo | Cosmo Technologies | NME |
| 2018/11/8 | D10978 | R03BB08 | Revefenacin | Yupelri | Theravance Biopharma | NME |
| 2018/11/2 | D11012 | L01ED05 | Lorlatinib | Lorbrena | Pfizer | NME |
| 2018/10/24 | D11021 | J05AX25 | Baloxavir marboxil | Xofluza | Shionogi | NME |
| 2018/10/16 | D10733 | L01XK04 | Talazoparib tosylate | Talzenna | Pfizer | NME |
| 2018/10/5 | D10941 | N07XX15 | Inotersen sodium | Tegsedi | Ionis Pharmaceuticals | NME |
| 2018/10/5 | D11017 | L03AX21 | Elapegademase | Revcovi | Leadiant Biosciences | BLA |
| 2018/10/3 | D09940 | J01AA15 | Omadacycline tosylate | Nuzyra | Paratek Pharmaceutical | NME |
| 2018/10/1 | D10666 | J01AA14 | Sarecycline | Seysara | Allergan plc and Paratek Pharmaceuticals | NME |
| 2018/9/28 | D11108 | L01FF06 | Cemiplimab | Libtayo | Regeneron Pharmaceuticals | BLA |
| 2018/9/27 | D10514 | L01EB07 | Dacomitinib | Vizimpro | Pfizer | NME |
| 2018/9/27 | D10936 | N02CD02 | Galcanezumab | Emgality | Eli Lilly | BLA |
| 2018/9/24 | D11658 | L01EM04 | Duvelisib | Copiktra | Verastem Inc | NME |
| 2018/9/14 | D11055 | N02CD03 | Fremanezumab | Ajovy | Teva Pharmaceuticals | BLA |
| 2018/9/13 | D09932 | L01FB02 | Moxetumomab pasudotox | Lumoxiti | AstraZeneca Pharmaceuticals | BLA |
| 2018/8/30 | D10624 | J05AG06 | Doravirine | Pifeltro | Merck Sharp Dohme | NME |
| 2018/8/23 | D11094 | B06AC05 | Lanadelumab | Takhzyro | Dyax Corporation | BLA |
| 2018/8/22 | D11028 | S01XA24 | Cenegermin | Exervate | Dompé farmaceutici SpA | BLA |
| 2018/8/20 | D05928 | N03AX17 | Stiripentol | Diacomit | Biocodex SA | NME |
| 2018/8/10 | D05031 | A16AX14 | Migalastat hydrochloride | Galafold | Amicus Therapeutics US | NME |
| 2018/8/10 | Segesterone acetate and ethinyl estradiol vaginal system | Annovera | The Population Council | |||
| 2018/8/10 | D10794 | N07XX12 | Patisiran sodium | Onpattro | Alnylam Pharmaceuticals | NME |
| 2018/8/8 | D09761 | L01FX09 | Mogamulizumab | Poteligeo | Kyowa Kirin | BLA |
| 2018/7/31 | D10476 | B02BX07 | Lusutrombopag | Mulpleta | Shionogi | NME |
| 2018/7/27 | Fish oil triglycerides | Omegaven | Fresenius Kabi USA | |||
| 2018/7/23 | D09336 | H01CC03 | Elagolix sodium | Orilissa | AbbVie | NME |
| 2018/7/20 | D10670 | P01BA07 | Tafenoquine succinate | Krintafel | GlaxoSmithKline | NME |
| 2018/7/20 | D11090 | L01XM02 | Ivosidenib | Tibsovo | Agios Pharmaceuticals | NME |
| 2018/7/13 | D09390 | J05AX24 | Tecovirimat | TPOXX | SIGA Technologies | NME |
| 2018/6/27 | D11053 | L01EC03 | Encorafenib | Braftovi | Array BioPharma | NME |
| 2018/6/27 | D10604 | L01EE03 | Binimetinib | Mektovi | Array BioPharma | NME |
| 2018/6/25 | D10655 | J01GB14 | Plazomicin sulfate | Zemdri | Achaogen | NME |
| 2018/6/25 | D10915 | N03AX24 | Cannabidiol | Epidiolex | GW Research | NME |
| 2018/5/31 | D10308 | L04AF02 | Baricitinib | Olumiant | Eli Lilly | NME |
| 2018/5/24 | D11077 | A16AB19 | Pegvaliase | Palynziq | BioMarin Pharmaceutical | BLA |
| 2018/5/21 | D10307 | B02BX08 | Avatrombopag maleate | Doptelet | AkaRx | NME |
| 2018/5/18 | D10727 | V03AE10 | Sodium zirconium cyclosilicate | Lokelma | AstraZeneca Pharmaceuticals | NME |
| 2018/5/17 | D10928 | N02CD01 | Erenumab | Aimovig | Amgen | BLA |
| 2018/4/19 | D10572 | A04AA55 | Fosnetupitant and palonosetron hydrochloride | Akynzeo | Helsinn Healthcare | |
| 2018/4/17 | D10913 | M05BX05 | Burosumab | Crysvita | Ultragenyx Pharmaceutical | BLA |
| 2018/4/17 | D09348 | B02BX09 | Fostamatinib disodium hexahydrate | Tavalisse | Rigel Pharmaceuticals | NME |
| 2018/3/20 | D10400 | L04AC17 | Tildrakizumab | Ilumya | Merck Sharp Dohme | BLA |
| 2018/3/6 | D09575 | J05AX23 | Ibalizumab | Trogarzo | TaiMed Biologics USA | BLA |
| 2018/2/14 | D11040 | L02BB05 | Apalutamide | Erleada | Janssen Biotech | NME |
| 2018/2/13 | D11042 | R07AX31 | Tezacaftor - Ivacaftor | Symdeko | Vertex Pharmaceuticals | NME |
| 2018/2/7 | D11039 | J05AR20 | Bictegravir, embitcitabine and tenofovir alafenamide | Biktarvy | Gilead Sciences | NME |
| 2018/1/26 | D11033 | V10XX04 | Lutetium (177Lu) dotatate | Lutathera | Advanced Accelerator Applications | NME |
| 2017/12/21 | D00150 | C01CX09 | Angiotensin II | Giapreza | La Jolla Pharmaceutical | NME |
| 2017/12/20 | D11043 | A10BK04 | Ertugliflozin | Steglatro | Merck Sharp Dohme | NME |
| 2017/12/20 | D10562 | V04CD06 | Macimorelin acetate | Macrilen | Aeterna Zentaris GmbH | NME |
| 2017/12/18 | D11031 | S01EX05 | Netarsudil mesylate | Rhopressa | Aerie Pharmaceuticals | NME |
| 2017/12/11 | D09544 | D06AX14 | Ozenoxacin | Xepi | Ferrer Internacional S.A. | NME |
| 2017/12/5 | D10025 | A10BJ06 | Semaglutide | Ozempic | Novo Nordisk Inc | NME |
| 2017/11/16 | D10821 | B02BX06 | Emicizumab | Hemlibra | Genentech | BLA |
| 2017/11/15 | D11004 | A16AB18 | Vestronidase alfa | Mepsevii | Ultragenyx Pharmaceutical | BLA |
| 2017/11/14 | D09874 | R03DX10 | Benralizumab | Fasenra | AstraZeneca AB | BLA |
| 2017/11/8 | D10801 | J05AX18 | Letermovir | Prevymis | Merck Sharp Dohme | NME |
| 2017/11/2 | D10441 | S01EE06 | Latanoprostene bunod | Vyzulta | Bausch & Lomb Incorporated | NME |
| 2017/10/31 | D10893 | L01EL02 | Acalabrutinib | Calquence | AstraZeneca Pharmaceuticals LP | NME |
| 2017/9/28 | D10688 | L01EF03 | Abemaciclib | Verzenio | Eli Lilly | NME |
| 2017/9/15 | D07353 | P01AB07 | Secnidazole | Solosec | Symbiomix Therapeutics | NME |
| 2017/9/14 | D10867 | L01EM02 | Copanlisib | Aliqopa | Bayer Healthcare Pharmaceuticals | NME |
| 2017/8/29 | D02489 | P01CA02 | Benznidazole | Benznidazole | Chemo Research | NME |
| 2017/8/29 | D11015 | J01DH52 | Meropenem ane vaborbactam | Vabomere | Rempex Pharmaceuticals | NME |
| 2017/8/17 | D08933 | L01FB01 | Inotuzumab ozogamicin | Besponsa | Wyeth Pharmaceuticals | BLA |
| 2017/8/3 | D11014 | J05AP57 | Glecaprevir and pibrentasvir | Mavyret | AbbVie | NME |
| 2017/8/1 | D11044 | L01XM01 | Enasidenib | Idhifa | Celgene Corporation | NME |
| 2017/7/18 | D10900 | J05AP56 | Sofosbuvir, velpatasvir and voxilaprevir | Vosevi | Gilead Sciences | NME |
| 2017/7/17 | D10898 | L01EH02 | Neratinib maleate | Nerlynx | Puma Biotechnology | NME |
| 2017/7/13 | D10438 | L04AC16 | Guselkumab | Tremfya | Janssen Biotech | BLA |
| 2017/6/23 | D08873 | B01AF04 | Betrixaban | Bevyxxa | Portola Pharmaceuticals | NME |
| 2017/6/19 | D09331 | J01MA23 | Delafloxacin meglumine | Baxdela | Melinta Therapeutics | NME |
| 2017/5/22 | D10161 | L04AC14 | Sarilumab | Kevzara | Sanofi Synthelabo | BLA |
| 2017/5/5 | D01552 | N07XX14 | Edaravone | Radicava | Mitsubishi Tanabe Pharma America | NME |
| 2017/5/1 | D10808 | L01FF03 | Durvalumab | Imfinzi | AstraZeneca UK | BLA |
| 2017/4/28 | D10885 | H05AA04 | Abaloparatide | Tymlos | Radius Health | NME |
| 2017/4/28 | D05029 | L01EX10 | Midostaurin | Rydapt | Novartis Pharmaceuticals | NME |
| 2017/4/28 | D10866 | L01ED04 | Brigatinib | Alunbrig | Ariad Pharmaceuticals | NME |
| 2017/4/27 | D10813 | A16AB17 | Cerliponase alfa | Brineura | BioMarin Pharmaceutical | BLA |
| 2017/4/11 | D10999 | N07XX13 | Valbenazine tosylate | Ingrezza | Neurocrine Biosciences | NME |
| 2017/4/3 | D10701 | N07XX16 | Deutetrabenazine | Austedo | Teva Pharmaceuticals | NME |
| 2017/3/28 | D05218 | L04AG08 | Ocrelizumab | Ocrevus | Genentech | BLA |
| 2017/3/28 | D10354 | D11AH05 | Dupilumab | Dupixent | Regeneron Pharmaceuticals | BLA |
| 2017/3/27 | D11895 | L01XK02 | Niraparib tosylate | Zejula | Tesaro | NME |
| 2017/3/23 | D10478 | A06AH05 | Naldemedine tosylate | Symproic | Shionogi | NME |
| 2017/3/23 | D10817 | L01FF04 | Avelumab | Bavencio | EMD Serono | BLA |
| 2017/3/23 | D10191 | N04BD03 | Safinamide mesylate | Xadago | Newron Pharmaceuticals | NME |
| 2017/3/21 | D10979 | L01EF02 | Ribociclib succinate | Kisqali | Novartis Pharmaceuticals | NME |
| 2017/3/17 | D12874 | J07BB03 | Influenza vaccine live, intranasal | Flumist | MedImmune, LLC | BLA |
| 2017/2/28 | D09974 | A16AX15 | Telotristat ethyl | Xermelo | Lexicon Pharmaceuticals | NME |
| 2017/2/15 | D10061 | L04AC12 | Brodalumab | Siliq | Valeant Pharmaceuticals | BLA |
| 2017/2/9 | D03671 | H02AB13 | Deflazacort | Emflaza | Marathon Pharmaceuticals | NME |
| 2017/2/8 | D10677 | H05BX04 | Etelcalcetide hydrochloride | Parsavib | KAI Pharmaceuticals | NME |
| 2017/1/19 | D09948 | A06AX07 | Plecanatide | Trulance | Synergy Pharmaceuticals | NME |
| 2016/12/23 | D10791 | M09AX07 | Nusinersen sodium | Spinraza | Biogen | NME |
| 2016/12/19 | D10982 | L01XK03 | Rucaparib camsylate | Rubraca | Clovis Oncology | NME |
| 2016/12/14 | D10873 | D11AH06 | Crisaborole | Eucrisa | Anacor Pharmaceuticals | NME |
| 2016/10/21 | D10453 | J06BC03 | Bezlotoxumab | Zinplava | Merck Sharp Dohme | BLA |
| 2016/10/19 | D09939 | L01FX10 | Olaratumab | Lartruvo | Eli Lilly | BLA |
| 2016/9/19 | D09900 | M09AX06 | Eteplirsen | Exondys 51 | Sarepta Therapeutics | NME |
| 2016/7/27 | D09729 | A10BJ03 | Lixisenatide | Adlyxin | Sanofi-Aventis US | NME |
| 2016/7/11 | D10374 | S01XA25 | Lifitegrast ophthalmic solution | Xiidra | Shire Development LLC | NME |
| 2016/6/28 | D10827 | J05AP55 | Sofosbuvir and velpatasvir | Epclusa | Gilead Sciences | NME |
| 2016/6/1 | Gallium Ga 68 dotatate | Netspot | AAA USA Inc | |||
| 2016/5/27 | D09360 | A05AA04 | Obeticholic acid | Ocaliva | Intercept Pharmaceuticals | NME |
| 2016/5/27 | D03639 | L04AC01 | Daclizumab | Zinbryta | Biogen | BLA |
| 2016/5/18 | D10773 | L01FF05 | Atezolizumab | Tecentriq | Genentech | BLA |
| 2016/4/29 | D08969 | N05AX17 | Pimavanserin | Nuplazid | ACADIA Pharmaceuticals | NME |
| 2016/4/11 | D10679 | L01XX52 | Venetoclax | Venclexta | AbbVie | NME |
| 2016/3/30 | D07423 | B01AX01 | Defibrotide sodium | Defitelio | Gentium SPA | NME |
| 2016/3/23 | D08985 | R03DX08 | Reslizumab | Cinqair | Teva Pharmaceuticals | BLA |
| 2016/3/22 | D10071 | L04AC13 | Ixekizumab | Taltz | Eli Lilly | BLA |
| 2016/3/21 | D10776 | J06BC04 | Obiltoxaximab | Anthim | Elusys Therapeutics | BLA |
| 2016/2/18 | D08879 | N03AX23 | Brivaracetam | Briviact | UCB Inc | NME |
| 2016/1/28 | D10778 | J05AP54 | Elbasvir and grazoprevir | Zepatier | Merck Sharp Dohme | NME |
| 2015/12/22 | D09921 | M04AB05 | Lesinurad | Zurampic | Ardea Biosciences | NME |
| 2015/12/22 | D09994 | B01AC27 | Selexipag | Uptravi | Actelion Pharmaceuticals Ltd | NME |
| 2015/12/15 | D05940 | V03AB35 | Sugammadex | Bridion | Organon Sub Merck | NME |
| 2015/12/11 | D10450 | L01ED03 | Alectinib | Alecensa | Genentech | NME |
| 2015/12/8 | D10377 | A16AB14 | Sebelipase alfa | Kanuma | Alexion Pharmaceuticals | BLA |
| 2015/11/30 | D09337 | L01FX08 | Elotuzumab | Empliciti | Bristol-Myers Squibb | BLA |
| 2015/11/24 | D10018 | L01FE03 | Necitumumab | Portrazza | Eli Lilly | BLA |
| 2015/11/20 | D10131 | L01XG03 | Ixazomib | Ninlaro | Millennium Pharmaceuticals | NME |
| 2015/11/16 | D10777 | L01FC01 | Daratumumab | Darzalex | Janssen Biotech | BLA |
| 2015/11/13 | D10766 | L01EB04 | Osimertinib | Tagrisso | AstraZeneca Pharmaceuticals | NME |
| 2015/11/10 | D10615 | L01EE02 | Cobimetinib | Cotellic | Genentech | NME |
| 2015/11/5 | D10755 | J05AR18 | Elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide | Genvoya | Gilead Sciences | NME |
| 2015/11/4 | D04923 | R03DX09 | Mepolizumab | Nucala | GlaxoSmithKline | BLA |
| 2015/10/23 | D10595 | A16AB13 | Asfotase alfa | Strensiq | Alexion Pharmaceuticals | BLA |
| 2015/10/23 | D06199 | L01CX01 | Trabectedin | Yondelis | Janssen Products | NME |
| 2015/10/21 | D11037 | V03AE09 | Patiromer sorbitex calcium | Veltassa | Relypsa Inc | NME |
| 2015/10/16 | D10741 | V03AB37 | Idarucizumab | Praxbind | Boehringer Ingelheim | BLA |
| 2015/10/6 | D10364 | N05AX12 | Aripiprazole lauroxil | Aristada | Alkermes | NME |
| 2015/9/25 | D09727 | A10AE06 | Insulin degludec | Tresiba | Novo Nordisk Inc | NME |
| 2015/9/22 | D10526 | L01BC59 | Trifluridine and tipiracil hydrochloride | Lonsurf | Taiho Oncology | NME |
| 2015/9/17 | D09876 | N05AX15 | Cariprazine | Vraylar | Forest Research Institute | NME |
| 2015/9/4 | D09985 | A16AX13 | Uridine triacetate | Xuriden | Wellstat Therapeutics | NME |
| 2015/9/2 | D08988 | A04AD14 | Rolapitant hydrochloride | Varubi | Tesaro Inc | NME |
| 2015/8/27 | D10557 | C10AX13 | Evolocumab | Repatha | Amgen | BLA |
| 2015/8/18 | D02577 | G02CX02 | Flibanserin | Addyi | Sprout Pharmaceuticals | NME |
| 2015/7/24 | D10105 | J05AP07 | Daclatasvir | Daklinza | Bristol-Myers Squibb | NME |
| 2015/7/24 | D10729 | L01XJ02 | Sonidegib | Odomzo | Novartis Pharmaceuticals | NME |
| 2015/7/24 | D10335 | C10AX14 | Alirocumab | Praluent | Sanofi-Aventis | BLA |
| 2015/7/10 | D10309 | N05AX16 | Brexpiprazole | Rexulti | Otsuka Pharmaceutical | NME |
| 2015/7/7 | D10226 | C09DX04 | Sacubitril - Valsartan | Entresto | Novartis Pharmaceuticals | NME |
| 2015/7/2 | D10685 | R07AX30 | Lumacaftor and ivacaftor | Orkambi | Vertex Pharmaceuticals | NME |
| 2015/6/22 | D03359 | B01AC25 | Cangrelor | Kengreal | Medicines Company | NME |
| 2015/5/27 | D10403 | A07DA06 | Eluxadoline | Viberzi | Furiex Pharmaceuticals | NME |
| 2015/4/29 | D10781 | D11AX24 | Deoxycholic acid | Kybella | Kythera Biopharmaceuticals | NME |
| 2015/4/15 | D08095 | C01EB17 | Ivabradine | Corlanor | Amgen | NME |
| 2015/3/17 | D10699 | A05AA03 | Cholic acid | Cholbam | Asklepion Pharmaceuticals LLC | NME |
| 2015/3/10 | D10559 | L01FX06 | Dinutuximab | Unituxin | United Therapies | BLA |
| 2015/3/6 | D10643 | Isavuconazonium sulfate | Cresemba | Astellas | NME | |
| 2015/2/25 | D10779 | J01DD52 | Ceftazidime-avibactam | Avycaz | Cerexa | NME |
| 2015/2/23 | D10019 | L01XH03 | Panobinostat | Farydak | Novartis Pharmaceuticals | NME |
| 2015/2/13 | D09920 | L01EX08 | Lenvatinib | Lenvima | Eisai | NME |
| 2015/2/3 | D10372 | L01EF01 | Palbociclib | Ibrance | Pfizer | NME |
| 2015/1/23 | D05364 | H05AA03 | Parathyroid hormone | Natpara | NPS Pharmaceuticals | BLA |
| 2015/1/21 | D09967 | L04AC10 | Secukinumab | Cosentyx | Novartis Pharmaceuticals | BLA |
| 2015/1/8 | D09546 | B01AF03 | Edoxaban | Savaysa | Daiichi Sankyo | NME |
| 2014/12/22 | D10316 | L01FF01 | Nivolumab | Opdivo | Bristol-Myers Squibb | BLA |
| 2014/12/19 | D03829 | J05AH03 | Peramivir | Rapivab | BioCryst | NME |
| 2014/12/19 | D10577 | J01DI54 | Ceftolozane - Tazobactam | Zerbaxa | Cubist Pharmaceuticals | NME |
| 2014/12/19 | D10582 | J05AP52 | Ombitasvir - Paritaprevir - Ritonavir with Dasabuvir | Viekira Pak | AbbVie | NME |
| 2014/12/19 | D09730 | L01XK01 | Olaparib | Lynparza | AstraZeneca Pharmaceuticals | NME |
| 2014/12/17 | D10575 | Finafloxacin otic suspension | Xtoro | Alcon Research Ltd | NME | |
| 2014/12/3 | D09325 | L01FX07 | Blinatumomab | Blincyto | Amgen | BLA |
| 2014/10/15 | D01583 | L04AX05 | Pirfenidone | Esbriet | InterMune | NME |
| 2014/10/15 | D10396 | L01EX09 | Nintedanib esylate | Ofev | Boehringer Ingelheim | NME |
| 2014/10/10 | D05962 | V08DA05 | Sulfur hexafluoride lipid microsphere | Lumason | Bracco Diagnostics | |
| 2014/10/10 | D10572 | A04AA55 | Netupitant - Palonosetron | Akynzeo | Helsinn Healthcare | NME |
| 2014/10/10 | D10578 | J05AP51 | Ledipasvir - Sofosbuvir | Harvoni | Gilead Sciences | NME |
| 2014/9/18 | D09889 | A10BJ05 | Dulaglutide | Trulicity | Eli Lilly | BLA |
| 2014/9/16 | D10375 | A06AH03 | Naloxegol oxalate | Movantik | AstraZeneca Pharmaceuticals | NME |
| 2014/9/4 | D10574 | L01FF02 | Pembrolizumab | Keytruda | Merck Sharp Dohme | BLA |
| 2014/8/19 | D09894 | A16AX10 | Eliglustat | Cerdelga | Genzyme | NME |
| 2014/8/15 | D10483 | L03AB13 | Peginterferon beta-1a | Plegridy | Biogen Idec Inc | BLA |
| 2014/8/13 | D10082 | N05CJ01 | Suvorexant | Belsomra | Merck Sharp Dohme | NME |
| 2014/8/6 | D05271 | J01XA05 | Oritavancin | Orbactiv | Medicines Company | NME |
| 2014/8/1 | D10459 | A10BK03 | Empagliflozin | Jardiance | Boehringer Ingelheim | NME |
| 2014/7/31 | D10020 | R03AC19 | Olodaterol hydrochloride | Striverdi Respimat | Boehringer Ingelheim | NME |
| 2014/7/23 | D10560 | L01EM01 | Idelalisib | Zydelig | Gilead Sciences | NME |
| 2014/7/7 | D10169 | D01AE24 | Tavaborole | Kerydin | Anacor Pharmaceuticals | NME |
| 2014/7/3 | D08870 | L01XH04 | Belinostat | Beleodaq | Spectrum Pharmaceuticals | NME |
| 2014/6/20 | D09686 | J01XX11 | Tedizolid phosphate | Sivextro | Cubist Pharmaceuticals | NME |
| 2014/6/6 | D10021 | D01AC19 | Efinaconazole | Jublia | Dow Pharmaceutical | NME |
| 2014/5/23 | D03640 | J01XA04 | Dalbavancin | Dalvance | Durata Therapeutics International | NME |
| 2014/5/20 | D08083 | L04AG05 | Vedolizumab | Entyvio | Takeda Pharmaceuticals USA | BLA |
| 2014/5/8 | D09766 | B01AC26 | Vorapaxar | Zontivity | Merck Sharp Dohme | NME |
| 2014/4/29 | D10551 | L01ED02 | Ceritinib | Zykadia | Novartis Pharmaceuticals | NME |
| 2014/4/23 | D09669 | L04AC11 | Siltuximab | Sylvant | Janssen Biotech | BLA |
| 2014/4/21 | D09371 | L01FG02 | Ramucirumab | Cyramza | Eli Lilly | BLA |
| 2014/4/15 | D08843 | A10BJ04 | Albiglutide | Tanzeum | GlaxoSmithKline | BLA |
| 2014/3/21 | D08860 | L04AA32 | Apremilast | Otezla | Celgene | NME |
| 2014/3/19 | D02494 | P01CX04 | Miltefosine | Impavido | Knight Therapeutics | NME |
| 2014/3/19 | D10002 | V09AX06 | Florbetaben F18 | Neuraceq | Piramal Imaging | NME |
| 2014/2/24 | D05014 | A16AA07 | Metreleptin | Myalept | Amylin Pharmaceuticals LLC | BLA |
| 2014/2/18 | D01277 | C01CA27 | Droxidopa | Northera | Lundbeck NA Ltd | NME |
| 2014/2/14 | D10333 | A16AB12 | Elosulfase alfa | Vimizim | BioMarin Pharmaceutical | BLA |
| 2014/1/31 | D09388 | N05CH03 | Tasimelteon | Hetlioz | Vanda Pharmaceuticals | NME |
| 2014/1/8 | D09763 | A10BK01 | Dapagliflozin | Farxiga | AstraZeneca AB | NME |
| 2013/12/18 | D10533 | R03AL03 | Umeclidinium - Vilanterol | Anoro Ellipta | GlaxoSmithKline | NME |
| 2013/12/6 | D10366 | J05AP08 | Sofosbuvir | Sovaldi | Gilead Sciences | NME |
| 2013/11/22 | D10469 | J05AP05 | Simeprevir sodium | Olysio | Janssen Products | NME |
| 2013/11/14 | D01980 | D01AC18 | Luliconazole | Luzu | Medicis | NME |
| 2013/11/13 | D10223 | L01EL01 | Ibrutinib | Imbruvica | Pharmacyclics | NME |
| 2013/11/8 | D09612 | N03AF04 | Eslicarbazepine acetate | Aptiom | Sunovion Pharmaceuticals | NME |
| 2013/11/1 | D09321 | L01FA03 | Obinutuzumab | Gazyva | Genentech | BLA |
| 2013/10/25 | D10231 | V09AX04 | Flutemetamol F18 | Vizamyl | GE Healthcare | NME |
| 2013/10/18 | D10135 | C02KX04 | Macitentan | Opsumit | Actelion Pharmaceuticals Ltd | NME |
| 2013/10/8 | D09572 | C02KX05 | Riociguat | Adempas | Bayer HealthCare | NME |
| 2013/10/3 | D10579 | G03CC07 | Conjugated estrogens - Bazedoxifene | Duavee | Wyeth Pharmaceuticals Pfizer | NME |
| 2013/9/30 | D10185 | N06AX26 | Vortioxetine | Brintellix | Takeda Pharmaceuticals USA | NME |
| 2013/8/12 | D10113 | J05AJ03 | Dolutegravir | Tivicay | ViiV Healthcare | NME |
| 2013/7/12 | D09733 | L01EB03 | Afatinib | Gilotrif | Boehringer Ingelheim | NME |
| 2013/5/29 | D10176 | L01EE01 | Trametinib | Mekinist | GlaxoSmithKline | NME |
| 2013/5/29 | D10104 | L01EC02 | Dabrafenib | Tafinlar | GlaxoSmithKline | NME |
| 2013/5/15 | D10398 | V10XX03 | Radium-223 dichloride | Xofigo | Bayer HealthCare | NME |
| 2013/5/10 | D10501 | R03AK10 | Fluticasone furoate - Vilanterol | Breo Ellipta | Glaxo Group Ltd | NME |
| 2013/3/29 | D09592 | A10BK02 | Canagliflozin | Invokana | Janssen Pharmaceuticals | NME |
| 2013/3/27 | D03846 | L04AX07 | Dimethyl fumarate | Tecfidera | Biogen Idec Inc | NME |
| 2013/3/20 | D03355 | V08CA02 | Gadoterate meglumine | Dotarem | Guerbet | NME |
| 2013/3/13 | D11543 | V09IA09 | Technetium Tc 99m tilmanocept | Lymphoseek | Navidea Biopharmaceuticals | |
| 2013/2/26 | D08958 | G03XC05 | Ospemifene | Osphena | Shionogi | NME |
| 2013/2/22 | D09980 | L01FD03 | Ado-trastuzumab emtansine | Kadcyla | Genentech | BLA |
| 2013/2/8 | D08976 | L04AX06 | Pomalidomide | Pomalyst | Celgene | NME |
| 2013/1/29 | D08946 | C10AX11 | Mipomersen sodium | Kynamro | Genzyme | NME |
| 2013/1/25 | D06553 | A10BH04 | Alogliptin | Nesina | Takeda Pharmaceuticals USA | NME |
| 2012/12/31 | D03605 | A07XA06 | Crofelemer | Fulyzaq | Salix Pharmaceuticals | NME |
| 2012/12/28 | D09873 | J04AK05 | Bedaquiline | Sirturo | Janssen Therapeutics | NME |
| 2012/12/28 | D03213 | B01AF02 | Apixaban | Eliquis | Bristol-Myers Squibb | NME |
| 2012/12/21 | D09638 | C10AX12 | Lomitapide | Juxtapid | Aegerion | NME |
| 2012/12/21 | D06053 | A16AX08 | Teduglutide | Gattex | NPS Pharmaceuticals | NME |
| 2012/12/14 | D10497 | H01CB05 | Pasireotide | Signifor | Novartis | NME |
| 2012/12/14 | D05706 | J06BC02 | Raxibacumab | raxibacumab | Human Genome Sciences | BLA |
| 2012/12/14 | D09951 | L01EA05 | Ponatinib | Iclusig | ARIAD | NME |
| 2012/11/29 | D10095 | L01EX07 | Cabozantinib | Cometriq | Exelixis | NME |
| 2012/11/6 | D09783 | L04AF01 | Tofacitinib | Xeljanz | PF Prism CV | NME |
| 2012/10/26 | D08956 | L01XX40 | Omacetaxine mepesuccinate | Synribo | Ivax International | NME |
| 2012/10/22 | D10780 | N03AX22 | Perampanel | Fycompa | Eisai | NME |
| 2012/10/17 | D09646 | S01XA22 | Ocriplasmin | Jetrea | ThromboGenics | BLA |
| 2012/9/27 | D10137 | L01EX05 | Regorafenib | Stivarga | Bayer HealthCare | NME |
| 2012/9/12 | D10498 | Choline C-11 | Choline C 11 Injection | Mayo Clinic PET Radiochemistry Facility | NME | |
| 2012/9/12 | D10172 | L04AK02 | Teriflunomide | Aubagio | Sanofi-Aventis US | NME |
| 2012/9/4 | D09728 | L01EA04 | Bosutinib | Bosulif | Wyeth Pharmaceuticals Inc | NME |
| 2012/8/31 | D10218 | L02BB04 | Enzalutamide | Xtandi | Astellas | NME |
| 2012/8/30 | D09355 | A06AX04 | Linaclotide | Linzess | Forest Laboratories | NME |
| 2012/8/29 | D03235 | L03AA02 | Tbo-filgrastim | Neutroval | Sicor Biotech | BLA |
| 2012/8/27 | D10756 | J05AR09 | Elvitegravir - Cobicistat - Emtricitabine - Tenofovir disoproxil fumarate | Stribild | Gilead Sciences | NME |
| 2012/8/3 | D09574 | L01XX44 | Ziv-Aflibercept | Zaltrap | Sanofi-Aventis US | BLA |
| 2012/7/23 | D08837 | R03BB05 | Aclidinium Bromide | Tudorza Pressair | Forest Laboratories | NME |
| 2012/7/20 | D08880 | L01XG02 | Carfilzomib | Kyprolis | Onyx Pharmaceuticals | NME |
| 2012/7/16 | D10793 | A06AB58 | Sodium picosulfate - Magnesium oxide - Citric acid | Prepopik | Ferring Pharmaceuticals | |
| 2012/6/28 | D09535 | G04BD12 | Mirabegron | Myrbetriq | Astellas Pharma US | NME |
| 2012/6/27 | D06613 | A08AA11 | Lorcaserin hydrochloride | Belviq | Eisai | NME |
| 2012/6/8 | D05446 | L01FD02 | Pertuzumab | Perjeta | Genentech | BLA |
| 2012/5/1 | D09675 | A16AB11 | Taliglucerase alfa | Elelyso | Pfizer | NME |
| 2012/4/27 | D03217 | G04BE10 | Avanafil | Stendra | VIVUS | NME |
| 2012/4/6 | D09617 | V09AX05 | Florbetapir F-18 | Amyvid | Avid Radiopharmaceuticals | NME |
| 2012/3/27 | D09947 | B03XA04 | Peginesatide | Omontys | Takeda Pharmaceuticals USA | NME |
| 2012/3/6 | D04792 | Lucinactant | Surfaxin | Discovery Laboratories | NME | |
| 2012/2/10 | D06274 | S01EE05 | Tafluprost | Zioptan | Oak Pharmaceuticals | NME |
| 2012/1/31 | D09916 | R07AX02 | Ivacaftor | Kalydeco | Vertex Pharmaceuticals | NME |
| 2012/1/30 | D09992 | L01XJ01 | Vismodegib | Erivedge | Genentech | NME |
| 2012/1/27 | D03218 | L01EK01 | Axitinib | Inlyta | Pfizer | NME |
| 2012/1/23 | D09393 | D06BX02 | Ingenol mebutate | Picato | Leo Pharma AS | NME |
| 2012/1/17 | D10260 | V03AF09 | Glucarpidase | Voraxaze | BTG International | BLA |
| 2011/11/18 | D09574 | S01LA05 | Aflibercept | Eylea | Regeneron Pharmaceuticals | BLA |
| 2011/11/18 | D02997 | L01XX02 | Asparaginase Erwinia chrysanthemi | Erwinaze | EUSA Pharma USA | BLA |
| 2011/11/16 | D09960 | L01EJ01 | Ruxolitinib | Jakafi | Incyte Corporation | NME |
| 2011/10/24 | D01253 | N05BA09 | Clobazam | Onfi | Lundbeck LLC | NME |
| 2011/10/14 | D07416 | V03AC02 | Deferiprone | Ferriprox | ApoPharma | NME |
| 2011/8/26 | D09731 | L01ED01 | Crizotinib | Xalkori | PF Prism CV | NME |
| 2011/8/25 | D04492 | B06AC02 | Icatibant | Firazyr | Shire Orphan Therapies | NME |
| 2011/8/19 | D09587 | L01FX05 | Brentuximab vedotin | Adcetris | Seattle Genetics | BLA |
| 2011/8/17 | D09996 | L01EC01 | Vemurafenib | Zelboraf | Hoffmann-La Roche | NME |
| 2011/7/20 | D09017 | B01AC24 | Ticagrelor | Brilinta | AstraZeneca LP | NME |
| 2011/7/1 | D07086 | B01AF01 | Rivaroxaban | Xarelto | Janssen Pharmaceuticals | NME |
| 2011/7/1 | D09319 | R03AC18 | Indacaterol | Arcapta Neohaler | Novartis | NME |
| 2011/6/15 | D03222 | L04AA28 | Belatacept | Nulojix | Bristol-Myers Squibb | BLA |
| 2011/6/10 | D09569 | N03AX21 | Ezogabine | Potiga | GlaxoSmithKline | NME |
| 2011/5/27 | D09394 | A07AA12 | Fidaxomicin | Dificid | Cubist Pharmaceuticals | NME |
| 2011/5/23 | D09012 | J05AP02 | Telaprevir | Incivek | Vertex Pharmaceuticals | NME |
| 2011/5/20 | D09958 | J05AG05 | Rilpivirine | Edurant | Janssen Products | NME |
| 2011/5/13 | D08876 | J05AP03 | Boceprevir | Victrelis | Merck Sharp Dohme | NME |
| 2011/5/2 | D09566 | A10BH05 | Linagliptin | Tradjenta | Boehringer Ingelheim | NME |
| 2011/4/28 | D09701 | L02BX03 | Abiraterone acetate | Zytiga | Janssen Biotech | NME |
| 2011/4/6 | D06407 | L01EX04 | Vandetanib | Caprelsa | IPR Pharmaceuticals | NME |
| 2011/4/6 | D09539 | N02BF01 | Gabapentin enacarbil | Horizant | XenoPort | NME |
| 2011/3/25 | D04603 | L01FX04 | Ipilimumab | Yervoy | Bristol-Myers Squibb | BLA |
| 2011/3/14 | D07420 | V08CA09 | Gadobutrol | Gadavist | Bayer HealthCare | NME |
| 2011/3/9 | D03068 | L04AG04 | Belimumab | Benlysta | Human Genome Sciences | BLA |
| 2011/2/28 | D05744 | R03DX07 | Roflumilast | Daliresp | Forest Research Institute | NME |
| 2011/2/25 | D08865 | C09CA09 | Azilsartan kamedoxomil | Edarbi | Arbor Pharmaceuticals Ireland | NME |
| 2011/1/21 | D09699 | N06AX24 | Vilazodone hydrochloride | Viibryd | Forest Laboratories | NME |
| 2011/1/18 | D09384 | Spinosad | Natroba | ParaPRO LLC | NME | |
| 2011/1/14 | D10014 | V09AB03 | Ioflupane I-123 | Datscan | GE Healthcare | NME |
| 2010/11/15 | D08914 | L01XX41 | Eribulin mesylate | Eribulin mesylate | Eisai | NME |
| 2010/11/10 | D09015 | H01AC06 | Tesamorelin | Egrifta | Theratechnologies | NME |
| 2010/10/29 | D08884 | J01DI02 | Ceftaroline fosamil | Ceftaroline fosamil for injection | Cerexa | NME |
| 2010/10/28 | D04820 | N05AE05 | Lurasidone hydrochloride | Lurasidone HCl | Sunovion Pharmaceuticals | NME |
| 2010/10/19 | D07082 | B01AE07 | Dabigatran etexilate mesylate | Pradaxa | Boehringer Ingelheim | NME |
| 2010/9/21 | D04187 | L04AE01 | Fingolimod hydrochloride | Fingolimod HCl oral capsules | Novartis Pharmaceuticals | NME |
| 2010/9/14 | D09316 | M04AX02 | Pegloticase | Krystexxa | Savient Pharmaceuticals | BLA |
| 2010/8/13 | D09687 | G03AD02 G03XB02 |
Ulipristal acetate | Ella | Laboratoire HRA Pharma | NME |
| 2010/7/30 | D10012 | Incobotulinumtoxin A | Xeomin | Merz Pharmaceuticals GmbH | BLA | |
| 2010/7/28 | D06552 | S01GX11 | Alcaftadine | Lastacaft | Vistakon Pharmaceuticals LLC | NME |
| 2010/6/17 | D10452 | L01CD04 | Cabazitaxel | Jevtana | Sanofi-Aventis US | NME |
| 2010/6/1 | D03684 | M05BX04 | Denosumab | Prolia | Amgen | BLA |
| 2010/5/24 | D03207 | A16AB07 | Alglucosidase alfa2 | Lumizyme | Genzyme | |
| 2010/5/6 | D10461 | G03AB08 | Estradial valerate - Dienogest | Natazia | Bayer HealthCare Pharmaceuticals | NME |
| 2010/3/30 | D01993 | C05BB02 | Polidocanol | Asclera | Chemische Fabrik Kreussler & Co GmbH | NME |
| 2010/3/18 | D07130 | A16AA05 | Carglumic acid | Carbaglu | Orphan Europe | NME |
| 2010/2/26 | D09029 | A16AB10 | Velaglucerase alfa | Vpriv | Shire Human Genetic Therapies | NME |
| 2010/2/2 | D09596 | M09AB02 | Clostridial collagenase | Xiaflex | Auxilium Pharmaceuticals | BLA |
| 2010/1/25 | D06404 | A10BJ02 | Liraglutide | Victoza | Novo Nordisk Inc | NME |
| 2010/1/22 | D04127 | N07XX07 | Dalfampridine | Ampyra | Acorda Therapeutics | NME |
| 2010/1/8 | D02596 | L04AC07 | Tocilizumab | Actemra | Genentech | BLA |
| 2009/12/1 | D03931 | B06AC03 | Ecallantide | Kalbitor | Dyax Corporation | BLA |
| 2009/11/16 | D00250 | M02AB01 N01BX04 |
Capsaicin | Qutenza | NeurogesX | NME |
| 2009/11/5 | D06637 | L01XH02 | Romidepsin | Romidepsin for infusion | Gloucester Pharmaceuticals | NME |
| 2009/10/26 | D09314 | L01FA02 | Ofatumumab | Arzerra | Glaxo Group GlaxoSmithKline | BLA |
| 2009/10/19 | D05380 | L01EX03 | Pazopanib | Votrient tablets | GlaxoSmithKline | NME |
| 2009/9/25 | D09214 | L04AC05 | Ustekinumab | Stelara | Centocor Ortho Biotech | BLA |
| 2009/9/24 | D05589 | L01BA05 | Pralatrexate | Folotyn | Allos Therapeutics | NME |
| 2009/9/11 | D06057 | J01XA03 | Telavancin | Telavancin | Theravance | NME |
| 2009/9/8 | D01654 | Bepotastine besilate | Bepotastine besilate ophthalmic solution | ISTA Pharmaceuticals | NME | |
| 2009/8/21 | D00535 | N03AG04 | Vigabatrin | Sabril (Vigabatrin) tablet 500mg | Lundbeck Inc | NME |
| 2009/8/13 | D02995 | N05AH05 | Asenapine | Saphris | Organon USA | NME |
| 2009/8/3 | D01862 | C10AA08 | Pitavastatin | Livalo tablets | Kowa Research Institute | NME |
| 2009/7/31 | D10262 | A10BH03 | Saxagliptin | Onglyza | Bristol-Myers Squibb CO | NME |
| 2009/7/10 | D05597 | B01AC22 | Prasugrel | Effient | Eli Lilly | NME |
| 2009/7/1 | D03914 | C01BD07 | Dronedarone hydrochloride | Multaq | Sanofi-Aventis US | NME |
| 2009/6/17 | D09315 | L04AC08 | Canakinumab | Ilaris | Novartis Pharmaceuticals | BLA |
| 2009/5/28 | D08872 | S01AE08 | Besifloxacin | Besifloxacin HCl | Bausch & Lomb | NME |
| 2009/5/19 | D01213 | C03XA01 | Tolvaptan | Samsca | Otsuka America Pharmaceutical | NME |
| 2009/5/6 | D02666 | N05AX14 | Iloperidone | Fanapt | Vanda Pharmaceuticals | NME |
| 2009/4/29 | D09764 | Abobotulinumtoxin A | Dysport | Ipsen Biopharm Ltd | BLA | |
| 2009/4/24 | D04358 | L04AB06 | Golimumab | Simponi | Centocor Ortho Biotech | BLA |
| 2009/4/9 | D00077 | P03AX06 | Benzyl alcohol | Ulesfia | Sciele Pharma | NME |
| 2009/4/7 | D02484 | P01BF01 | Artemether - Lumefantrine | Coartem | Novartis Pharmaceuticals | NME |
| 2009/3/30 | D02714 | L01EG02 | Everolimus | Afinitor | Novartis Pharmaceuticals | NME |
| 2009/2/13 | D01206 | M04AA03 | Febuxostat | Uloric (Febuxostat) tablets | Takeda Pharmaceuticals North America | NME |
| 2009/1/14 | D01107 | N06AX17 | Milnacipran HCl tablets | Savella tablets | Cypress Bioscience | NME |
| 2008/12/24 | D09400 | L02BX02 | Degarelix acetate | Degarelix | Ferring | NME |
| 2008/12/22 | D04286 | V08CA11 | Gadofosveset trisodium | Vasovist | EPIX | NME |
| 2008/12/15 | D08971 | L03AX16 | Plerixafor | Mozobil | Genzyme | NME |
| 2008/12/12 | D04257 | N01AX10 | Fospropofol disodium | Lusedra | Eisai Medical | NME |
| 2008/11/20 | D03978 | B02BX05 | Eltrombopag olamine | Promacta | GlaxoSmithKline | NME |
| 2008/11/20 | D10199 | N02AX06 | Tapentadol hydrochloride | Tapentadol | Ortho-McNeil-Janssen | NME |
| 2008/11/14 | D05775 | N03AF03 | Rufinamide | Banzel oral tabs | Eisai | NME |
| 2008/10/31 | D08923 | G04BD11 | Fesoterodine fumarate | Toviaz | Pfizer | NME |
| 2008/10/28 | D07299 | N03AX18 | Lacosamide | Vimpat rablets | Schwarz Biosciences | NME |
| 2008/10/8 | D01965 | G04CA04 | Silodosin | Rapaflo | Watson Labs | NME |
| 2008/9/19 | D04559 | V09IX01 | Iobenguane | AdreView | GE Healthcare | NME |
| 2008/8/22 | D08990 | B02BX04 | Romiplostim | Nplate | Amgen | BLA |
| 2008/8/15 | D08575 | N07XX06 | Tetrabenazine | Xenazine | Prestwick | NME |
| 2008/8/1 | D08892 | C08CA16 | Clevidipine butyrate | Cleviprex | Medicines Company | NME |
| 2008/7/3 | D04288 | V08CA10 | Gadoxetate disodium | Eovist injection | Bayer | NME |
| 2008/6/23 | D01266 | D07AC19 | Difluprednate | Durezol | Sirion | NME |
| 2008/5/20 | D02878 | A06AH02 | Alvimopan | Entereg | Adolor | NME |
| 2008/4/24 | D06618 | A06AH01 | Methylnaltrexone bromide | Relistor | Progenics | NME |
| 2008/4/22 | D03441 | L04AB05 | Certolizumab pegol | Cimzia | UCB | BLA |
| 2008/4/10 | D05711 | C01EB21 | Regadenoson | Lexiscan | CV Therapeutics | NME |
| 2008/3/20 | D07085 | L01AA09 | Bendamustine hydrochloride | Treanda | Cephalon | NME |
| 2008/2/29 | D02570 | N06AX23 | Desvenlafaxine succinate | Pristiq | Wyeth | NME |
| 2008/2/27 | D06635 | L04AC04 | Rilonacept | Arcalyst | Regeneron | BLA |
| 2008/1/18 | D04112 | J05AG04 | Etravirine | Intelence | Tibotec | NME |
| 2007/12/17 | D06622 | C07AB12 | Nebivolol | Bystolic | Mylan Bertek | NME |
| 2007/12/13 | D01798 | A16AX07 | Sapropterin dihydrochloride | Kuvan | BioMarin | NME |
| 2007/11/14 | D09998 | B03XA03 | Methoxy polyethylene glycol-epoetin beta | Mircera | Hoffman La-Roche | BLA |
| 2007/10/29 | D06413 | L01EA03 | Nilotinib | Tasigna | Novartis | NME |
| 2007/10/16 | D04645 | L01DC04 | Ixabepilone | Ixempra | Bristol-Myers Squibb | NME |
| 2007/10/12 | D03895 | J01DH04 | Doripenem | Doribax | Johnson & Johnson | NME |
| 2007/10/12 | D07133 | J05AJ01 | Raltegravir potassium | Isentress | Merck | NME |
| 2007/8/30 | D04666 | H01CB03 | Lanreotide | Somatuline Depot | Biomeasure | NME |
| 2007/8/23 | D02915 | V09GX05 | Ammonia N 13 | Ammonia N13 | Feinstein | NME |
| 2007/8/6 | D06670 | J05AX09 | Maraviroc | Selzentry | Pfizer | NME |
| 2007/6/15 | D07077 | C02KX02 | Ambrisentan | Letairis | Gilead Sciences | NME |
| 2007/5/30 | D06068 | L01EG01 | Temsirolimus | Torisel | Wyeth | NME |
| 2007/5/9 | D05768 | N04BC09 | Rotigotine | Neupro | Schwarz BioSciences | NME |
| 2007/4/12 | D05720 | D06AX13 | Retapamulin | Altabax | GlaxoSmithKline | NME |
| 2007/3/16 | D03940 | L04AJ01 | Eculizumab | Soliris | Alexion | BLA |
| 2007/3/13 | D04024 | L01EH01 | Lapatinib | Tykerb | GlaxoSmithKline | NME |
| 2007/3/5 | D06412 | C09XA02 | Aliskiren | Tekturna | Novartis | NME |
| 2007/2/23 | D04747 | N06BA12 | Lisdexamfetamine dimesylate | Vyvanse | New River | NME |
| 2006/12/19 | D05339 | N05AX13 | Paliperidone | Invega | Janssen LP | NME |
| 2006/10/31 | D08997 | D06BB12 | Sinecatechins | Veregen | MediGene | NME |
| 2006/10/25 | D06675 | J05AF11 | Telbivudine | Tyzeka | Idenix | NME |
| 2006/10/20 | D01703 | R01AD13 R03BA08 |
Ciclesonide | Omnaris | Altana | NME |
| 2006/10/16 | D06645 | A10BH01 | Sitagliptin phosphate | Januvia | Merck | NME |
| 2006/10/6 | D06320 | L01XH01 | Vorinostat | Zolinza | Merck | NME |
| 2006/9/28 | D10245 | A02BD08 | Biskalcitrate - Metronidazole - Tetracycline hydrochloride | Pylera | Axcan Scandipharm | NME |
| 2006/9/27 | D05350 | L01FE02 | Panitumumab | Vectibix | amgen | BLA |
| 2006/9/15 | D02555 | J02AC04 | Posaconazole | Noxafil | Schering | NME |
| 2006/7/24 | D04499 | A16AB09 | Idursulfase | Elaprase | Shire Human Genetic Therapies | BLA |
| 2006/7/21 | Avobenzone - Ecamsule - Octocrylene | Anthelios SX | L'Oreal | |||
| 2006/6/30 | D05697 | S01LA04 | Ranibizumab | Lucentis | Genentech | BLA |
| 2006/6/28 | D06414 | L01EA02 | Dasatinib | Sprycel | Bristol-Myers Squibb | NME |
| 2006/6/23 | D06478 | J05AE10 | Darunavir | Prezista | Tibotec | NME |
| 2006/5/16 | D02562 | N04BD02 | Rasagiline mesylate | Azilect | Teva | NME |
| 2006/5/10 | D06282 | N07BA03 | Varenicline | Chantix | Pfizer | NME |
| 2006/5/2 | D03665 | L01BC08 | Decitabine | Dacogen | MGI Pharma | NME |
| 2006/4/28 | D03207 | A16AB07 | Alglucosidase alfa | Myozyme | Genzyme | BLA |
| 2006/2/17 | D03211 | J02AX06 | Anidulafungin | Eraxis | Vicuron | NME |
| 2006/1/31 | D04790 | A06AX03 | Lubiprostone | Amitiza | Sucampo | NME |
| 2006/1/27 | D05700 | C01EB18 | Ranolazine | Ranexa | CV Therapeutics | NME |
| 2006/1/26 | D06402 | L01EX01 | Sunitinib malate | Sutent | Pfizer | NME |
| 2005/12/29 | D01236 | C03XA02 | Conivaptan hydrochloride | Vaprisol | Astellas | NME |
| 2005/12/27 | D04687 | L04AX04 | Lenalidomide | Revlimid | Celgene | NME |
| 2005/12/23 | D03203 | L04AA24 | Abatacept | Orencia | Bristol-Myers Squibb | BLA |
| 2005/12/20 | D06272 | L01EX02 | Sorafenib tosylate | Nexavar | Bayer | NME |
| 2005/12/12 | D04870 | H01AC05 | Mecasermin rinfabate [rDNA Origin] | Iplex | Insmed | NME |
| 2005/12/2 | D06604 | B06AA03 | Hyaluronidase | Hylenex recombinant | Halozyme | NME |
| 2005/11/2 | D03669 | V03AC03 | Deferasirox | Exjade | Novartis | NME |
| 2005/10/28 | D05134 | L01BB07 | Nelarabine | Arranon | GlaxoSmithKline | NME |
| 2005/10/25 | D04456 | B06AA03 | Hyaluronidase | Hydase | PrimaPharm | |
| 2005/8/30 | D03297 | H01AC03 | Mecasermin | Increlex | Tercica | NME |
| 2005/8/19 | D05143 | S01BC10 | Nepafenac | Nevanac | Alcon | NME |
| 2005/7/22 | D02689 | N05CH02 | Ramelteon | Rozerem | Takeda Global | NME |
| 2005/6/22 | D08605 | J05AE09 | Tipranavir | Aptivus | Boehringer Ingelheim | NME |
| 2005/6/16 | D04539 | A10AE05 | Insulin detemir | Levemir | Novo Nordisk | NME |
| 2005/6/15 | D01079 | J01AA12 | Tigecycline | Tygacil | Wyeth Pharms | NME |
| 2005/5/31 | D06565 | A16AB08 | Galsulfase | Naglazyme | Biomarin Pharmaceutical Inc. | BLA |
| 2005/4/28 | D04121 | A10BJ01 | Exenatide | Byetta | Amylin | NME |
| 2005/3/29 | D04008 | J05AF10 | Entecavir | Baraclude | Bristol Myers Squibb | NME |
| 2005/3/16 | D05595 | A10BX05 | Pramlintide acetate | Symlin | Amylin | NME |
| 2005/3/16 | D02465 | J02AX05 | Micafungin sodium | Mycamine | Fujisawa | NME |
| 2004/12/30 | D02716 | N02BF02 | Pregabalin | Lyrica | Pfizer | NME |
| 2004/12/29 | D02721 | B01AC11 | Iloprost | Ventavis | Cotherix | NME |
| 2004/12/28 | D08686 | N02BG08 | Ziconotide | Prialt | Elan Pharms | NME |
| 2004/12/28 | D03546 | L01BB06 | Clofarabine | Clolar | Genzyme | NME |
| 2004/12/22 | D01699 | G04BD10 | Darifenacin hydrobromide | Enablex | Novartis | NME |
| 2004/12/17 | D05386 | S01LA03 | Pegaptanib sodium | Macugen | Eyetech Pharms | NME |
| 2004/12/16 | C19307 | S01KX02 | Trypan blue | Vision blue | Dorc International BV | NME |
| 2004/12/15 | D02624 | N05CF04 | Eszopiclone | Lunesta | Sepracor | NME |
| 2004/12/15 | D05338 | V03AF08 | Palifermin | Kepivance | Amgen | BLA |
| 2004/11/23 | D04283 | V08CA08 | Gadobenate dimeglumine | Multihance | Bracco | NME |
| 2004/11/23 | D06886 | L04AG03 | Natalizumab | Tysabri | Biogen Idec Inc. | BLA |
| 2004/11/19 | D01269 | G04BD08 | Solifenacin succinate | VESIcare | Yamanouchi | NME |
| 2004/11/18 | D04023 | L01EB02 | Erlotinib hydrochloride | Tarceva | OSI Pharms | NME |
| 2004/11/10 | D05255 | C10AX06 | Omega-3-acid ethyl esters | Omacor | Ross Prods | NME |
| 2004/10/26 | D04667 | V03AE03 | Lanthanum carbonate hydrate | Fosrenol | Shire Pharm | NME |
| 2004/10/26 | D04456 | B06AA03 | Hyaluronidase | Amphadase | Amphastar Pharm | NME |
| 2004/8/11 | D05419 | Pentetate calcium trisodium | Pentetate calcium trisodium | Pharma Hameln GmbH | NME | |
| 2004/8/11 | D09762 | Pentetate zinc trisodium | Pentetate zinc trisodium | Pharma Hameln GmbH | NME | |
| 2004/8/3 | D01179 | N06AX21 | Duloxetine hydrochloride | Cymbalta | Eli Lilly | NME |
| 2004/7/29 | D02780 | N07BB03 | Acamprosate calcium | Campral | Lipha | NME |
| 2004/7/2 | D06033 | Technetium Tc 99m fanolesomab | NeutroSpec | Palatin Technologies | BLA | |
| 2004/6/10 | D00015 | A16AA03 | L-Glutamine | NutreStore | Nutritional Restart | NME |
| 2004/5/28 | D01103 | G04BD09 | Trospium chloride | Sanctura | Indevus | NME |
| 2004/5/25 | D02554 | A07AA11 D06AX11 |
Rifaximin | Xifaxan | Salix Pharma | NME |
| 2004/5/19 | D03021 | L01BC07 | Azacitidine | Vidaza | Pharmion | NME |
| 2004/5/17 | D01426 | J01XD02 P01AB02 |
Tinidazole | Tindamax | Presutti Labs | NME |
| 2004/5/5 | D04455 | B06AA03 | Ovine hyaluronidase | Vitrase | Ista Pharms | NME |
| 2004/4/20 | D02004 | N04BC07 | Apomorphine hydrochloride | Apokyn | Bertek | NME |
| 2004/4/16 | D04540 | A10AB06 | Insulin glulisine | Apidra | Aventis Pharms | NME |
| 2004/4/9 | D02021 | V04CK01 | Secretin | ChiRhoStim | Chirhoclin | NME |
| 2004/4/1 | D01078 | J01FA15 | Telithromycin | Ketek | Aventis Pharms | NME |
| 2004/3/8 | D03505 | H05BX01 | Cinacalcet hydrochloride | Sensipar | Amgen | NME |
| 2004/2/26 | D06409 | L01FG01 | Bevacizumab | Avastin | Genentech | BLA |
| 2004/2/12 | D03455 | L01FE01 | Cetuximab | Erbitux | ImClone Systems | BLA |
| 2004/2/4 | D06503 | L01BA04 | Pemetrexed disodium heptahydrate | Alimta | Eli Lilly | NME |
| 2004/1/30 | D01929 | R03BB04 | Tiotropium bromide | Spiriva Handihaler | Boehringer Ingelheim | NME |
| 2003/12/10 | D08510 | D01AC14 G01AF19 |
Sertaconazole nitrate | Ertaczo | Mylan | NME |
| 2003/11/25 | D02738 | L02BX01 | Abarelix | Plenaxis | Praecis | NME |
| 2003/11/21 | D02008 | G04BE08 | Tadalafil | Cialis | Lilly | NME |
| 2003/10/16 | D04905 | N06DX01 | Memantine hydrochloride | Namenda | Forest Labs | NME |
| 2003/10/16 | D01713 | R06AX24 S01GX10 |
Epinastine hydrochloride | Elestat | Allergan | NME |
| 2003/10/2 | D05647 | V03AB31 | Prussian blue | Radiogardase | Heyl Chemisch-pharmazeutische Fabrik GmbH | NME |
| 2003/9/12 | D01080 | J01XX09 | Daptomycin | Cubicin | Cubist | NME |
| 2003/8/19 | D03260 | G04BE09 | Vardenafil hydrochloride | Levitra | Bayer | NME |
| 2003/8/12 | D01915 | C10AA07 | Rosuvastatin calcium | Crestor | IRP AstraZenca | NME |
| 2003/7/31 | D05032 | A16AX06 | Miglustat | Zavesca | Actelion | NME |
| 2003/7/25 | D05343 | A04AA05 | Palonosetron hydrochloride | Aloxi | Helsinn Healthcare S.A. | NME |
| 2003/7/2 | D01199 | J05AF09 | Emtricitabine | Emtriva | Gilead Sciences | NME |
| 2003/6/20 | D01276 | J05AE08 | Atazanavir | Reyataz | Bristol-Myers Squibb | NME |
| 2003/6/12 | D01692 | G04CA01 | Alfuzosin hydrochloride | Uroxatral | Sanofi-Synthelabo | NME |
| 2003/5/16 | D04486 | M05BA06 | Ibandronate sodium | Boniva | Hoffman-La Roche | NME |
| 2003/5/13 | D03150 | L01XG01 | Bortezomib | Velcade | Millennium Pharms | NME |
| 2003/5/5 | D01977 | L01EB01 | Gefitinib | Iressa | AstraZeneca | NME |
| 2003/4/4 | D02471 | J01MA15 | Gemifloxacin mesylate | Factive | LG Life Sciences, Ltd | NME |
| 2003/3/26 | D02968 | A04AD12 | Aprepitant | Emend | Merck | NME |
| 2003/3/25 | D05394 | H01AX01 | Pegvisomant | Somavert | Pharmacia & Upjohn | NME |
| 2003/3/13 | D02499 | J05AX07 | Enfuvirtide | Fuzeon | Hoffman-La Roche | NME |
| 2002/12/26 | D01973 | N02CC06 | Eletriptan hydrobromide | Relpax | Pfizer | NME |
| 2002/12/12 | D03266 | Icodextrin | Extraneal | Baxter Healthcare | NME | |
| 2002/11/26 | D02574 | N06BA09 | Atomoxetine hydrochloride | Strattera | Eli Lilly | NME |
| 2002/11/22 | D02486 | P01AX11 | Nitazoxanide | Alinia | Romak Labs | NME |
| 2002/11/15 | D01164 | N05AX12 | Aripiprazole | Abilify | Otsuka Pharmaceutical | NME |
| 2002/10/25 | D01966 | C10AX09 | Ezetimibe | Zetia | MSP Singapore | NME |
| 2002/9/27 | D01115 | C03DA04 | Eplerenone | Inspra | GD Searle | NME |
| 2002/9/20 | D01655 | J05AF08 | Adefovir dipivoxil | Hepsera | Gilead Sciences | NME |
| 2002/8/9 | D01790 | L01XA03 | Oxaliplatin | Eloxatin | Sanofi-Synthelabo | NME |
| 2002/7/24 | D02730 | A06AX06 | Tegaserod maleate | Zelnorm | Novartis Pharms | NME |
| 2002/7/17 | D05866 | N01AX11 N07XX04 |
Sodium oxybate | Xyrem | Orphan Medical | NME |
| 2002/5/31 | D05439 | V08CX01 | Perflexane phospholipid microspheres | Imagent | Alliance Pharm | NME |
| 2002/5/24 | D00578 | J02AC03 | Voriconazole | Vfend | Pfizer | NME |
| 2002/5/21 | D06213 | B01AC21 | Treprostinil Sodium | Remodulin | United Therapeutics | NME |
| 2002/4/25 | D01204 | C09CA08 | Olmesartan medoxomil | Benicar | Sankyo | NME |
| 2002/4/25 | D01161 | L02BA03 | Fulvestrant | Faslodex | AstraZeneca | NME |
| 2002/1/18 | D05177 | A16AX04 | Nitisinone | Orfadin | Swedish Orphan | NME |
| 2001/12/21 | D03693 | R06AX27 | Desloratadine | Clarinex | Schering | NME |
| 2001/12/13 | D05480 | D11AH02 | Pimecrolimus | Elidel | Novartis Pharms | NME |
| 2001/12/7 | D01844 | B01AX05 | Fondaparinux sodium | Arixtra | Fonda BV | NME |
| 2001/11/21 | D04049 | J01DH03 | Ertapenem sodium | Invanz | Merck | NME |
| 2001/11/20 | D10839 | G03AA13 | Norelgestromin - Ethinyl estradiol | Ortho Evra | RW Johnson | NME |
| 2001/11/20 | D01227 | C02KX01 | Bosentan | Tracleer | Actelion | NME |
| 2001/11/20 | D03820 | G04CB02 | Dutasteride | Avodart | Glaxo SmithKline | NME |
| 2001/11/16 | D02709 | M01AH03 | Valdecoxib | Bextra | Searle Pharms | NME |
| 2001/11/8 | D04264 | N02CC07 | Frovatriptan succinate | Frova | Elan Pharma | NME |
| 2001/10/26 | D01982 | J05AF07 | Tenofovir disoproxil fumarate | Viread | Gilead Sciences | NME |
| 2001/10/3 | D11655 | Etonogestrel - Ethinyl estradiol | NuvaRing | Organon | ||
| 2001/8/29 | D01628 | J01DD16 | Cefditoren pivoxil | Spectracef | TAP Pharm | NME |
| 2001/8/20 | D01968 | M05BA08 | Zoledronic acid | Zometa | Novartis Pharms | NME |
| 2001/8/10 | D05147 | C01DX19 | Nesiritide | Natrecor | Scios | NME |
| 2001/7/31 | D01738 | V08DA04 | Perflutren lipid microsphere | Definity | Dupont Pharms | NME |
| 2001/5/11 | D09741 | G03AA12 | Drospirenone - Ethinyl estradiol | Yasmin | Berlex Labs | NME |
| 2001/5/10 | D01441 | L01EA01 | Imatinib mesylate | Gleevec | Novartis Pharms | NME |
| 2001/5/7 | D02825 | N02CC05 | Almotriptan malate | Axert | Pharmacia & Upjohn | NME |
| 2001/3/16 | D01964 | S01EE04 | Travoprost | Travatan | Alcon Universal | NME |
| 2001/3/16 | D02724 | S01EE03 | Bimatoprost | Lumigan | Allergan | NME |
| 2001/2/28 | D02173 | N06DA04 | Galantamine hydrobromide | Reminyl | Janssen Research | NME |
| 2001/2/16 | D01373 | R03AC13 | Formoterol fumarate | Foradil Aerolizer | Novartis Pharms | NME |
| 2001/2/5 | D01939 | N05AE04 | Ziprasidone hydrochloride | Geodon | Pfizer | NME |
| 2001/1/26 | D02501 | J02AX04 | Caspofungin acetate | Cancidas | Merck Research Labs | NME |
| 2000/12/22 | D01111 | A10BX03 | Nateglinide | Starlix | Novartis Pharms | NME |
| 2000/12/15 | D03136 | B01AE06 | Bivalirudin | Angiomax | The Medicines Company | NME |
| 2000/9/28 | D00585 | G03XB01 | Mifepristone | Mifeprex | Population Council | NME |
| 2000/9/25 | D02106 | L01XX27 | Arsenic trioxide | Trisenox | Cell Therapeutics | NME |
| 2000/9/15 | D02498 | J05AR10 | Lopinavir - Ritonavir | Kaletra | Abbott Labs | NME |
| 2000/8/11 | D01685 | H01CC02 | Cetrorelix acetate | Cetrotide | Serono | NME |
| 2000/8/3 | D01452 | S01EE02 | Unoprostone isopropyl | Rescula | Ciba Vision | NME |
| 2000/7/25 | D03884 | D06BB11 | Docosanol | Abreva | SKB Cons Healthcare | NME |
| 2000/7/18 | D02715 | A07EC04 | Balsalazide disodium | Colazal | Salix Pharm | NME |
| 2000/7/14 | D06398 | B01AB10 | Tinzaparin sodium | Innohep | Dupont | NME |
| 2000/6/30 | D00181 | B01AE03 | Argatroban | Acova | Texas Biotech | NME |
| 2000/6/15 | D06248 | L02AE04 | Triptorelin pamoate | Trelstar Depot | Debio Recherche | NME |
| 2000/6/7 | D04475 | A10AB05 | Insulin aspart | NovoLog | Novo Nordisk | NME |
| 2000/5/26 | D03582 | C10AC04 | Colesevelam hydrochloride | Welchol | Sankyo Pharm | NME |
| 2000/5/17 | D03259 | L01FX02 | Gemtuzumab ozogamicin | Mylotarg | Wyeth-Ayerst | BLA |
| 2000/4/21 | D02558 | N06DA03 | Rivastigmine tartrate | Exelon | Novartis Pharms | NME |
| 2000/4/20 | D03250 | A10AE04 | Insulin glargine | Lantus | Aventis Pharms | NME |
| 2000/4/18 | D00947 | J01XX08 | Linezolid | Zyvox | Pharmacia & Upjohn | NME |
| 2000/4/13 | D00969 | M01AC06 | Meloxicam | Mobic | Boehringer Ingleheim Pharms | NME |
| 2000/4/12 | D01162 | S01LA01 | Verteporfin | Visudyne | QLT Photo | NME |
| 2000/4/3 | D11290 | N01BB58 | Articaine hydrochloride - Epinephrine | Septocaine | Deproco | NME |
| 2000/3/27 | D00538 | N03AX15 | Zonisamide | Zonegran | Dainippon Pharm | NME |
| 2000/2/17 | Perfluoro-polymethyl-isopropyl ether - Polytetrafluoro-ethylene | Skin exposure reduction paste against chemical warfare agents | U.S. Army | |||
| 2000/2/9 | D02829 | A03AE01 | Alosetron hydrochloride | Lotronex | Glaxo Wellcome | NME |
| 2000/2/2 | D02593 | A02BC02 | Pantoprazole sodium | Protonix | Wyeth-Ayerst | NME |
| 2000/1/14 | D00533 | N03AF02 | Oxcarbazepine | Trileptal | Novartis Pharms | NME |
| 2000/1/11 | D00661 | N07AX03 | Cevimeline hydrochloride | Evoxac | ShowBrand | NME |
| 1999/12/29 | D03106 | L01XF03 | Bexarotene | Targretin | Ligand Pharm | NME |
| 1999/12/23 | D00074 | R07AX01 | Nitric oxide | INOmax | INO Therapeutics | NME |
| 1999/12/17 | D01205 | N05CM18 | Dexmedetomidine hydrochloride | Precedex | Abbott Labs | NME |
| 1999/12/17 | D00589 | J01MA16 S01AE06 |
Gatifloxacin | Tequin | Bristol-Myers Squibb | NME |
| 1999/12/10 | Mequinol - tretinoin | Solage | Bristol-Myers Squibb | |||
| 1999/12/10 | D00874 | J01MA14 S01AE07 |
Moxifloxacin hydrochloride | Avelox | Bayer | NME |
| 1999/12/8 | D01646 | V08CA06 | Gadoversetamide | Optimark | Mallinckrodt | NME |
| 1999/12/3 | D02908 | L01XD04 | Aminolevulinic acid hydrochloride | Levulan Kerastick | DUSA Pharm | NME |
| 1999/11/30 | D00709 | N03AX14 | Levetiracetam | Keppra | UCB Pharm | NME |
| 1999/11/18 | D08402 | Poractant alfa | Curosurf | Dey Labs | NME | |
| 1999/10/27 | D00900 | J05AH02 | Oseltamivir phosphate | Tamiflu | Hoffmann-La Roche | NME |
| 1999/10/21 | D00963 | L02BG06 | Exemestane | Aromasin | Pharmacia & Upjohn | NME |
| 1999/10/19 | D00781 | N04BX02 | Entacapone | Comtan | Orion | NME |
| 1999/10/1 | D00647 | C01BD04 | Dofetilide | Tikosyn | Pfizer | NME |
| 1999/9/24 | D01088 | Pemirolast potassium | Alamast | Santen | NME | |
| 1999/9/21 | D00854 | J01FG02 | Quinupristin - Dalfopristin | Synercid IV | Rhone Poulenc Rorer | NME |
| 1999/9/15 | D00753 | L04AH01 | Sirolimus | Rapamune | Wyeth-Ayerst | NME |
| 1999/9/15 | D02214 | L01DB03 | Epirubicin hydrochloride | Ellence | Pharmacia & Upjohn | NME |
| 1999/8/19 | D00724 | A02BC04 | Rabeprazole sodium | Aciphex | Eisai (US) | NME |
| 1999/8/18 | D05703 | Rapacuronium bromide | Raplon | Organon | NME | |
| 1999/8/13 | D00530 | N05CF03 | Zaleplon | Sonata | Wyeth-Ayerst | NME |
| 1999/8/11 | D06067 | L01AX03 | Temozolomide | Temodar | Schering | NME |
| 1999/8/3 | D06030 | V09IA05 | Technetium Tc 99m depreotide | Neotect | Diatide | NME |
| 1999/7/29 | D04302 | H01CC01 | Ganirelix acetate | Antagon | Organon | NME |
| 1999/7/26 | D00902 | J05AH01 | Zanamivir | Relenza | Glaxo Wellcome | NME |
| 1999/7/15 | D00945 | A10BG03 | Pioglitazone hydrochloride | Actos | Takeda America | NME |
| 1999/7/2 | D01332 | R06AX17 S01GX08 |
Ketotifen fumarate | Zaditor | Ciba Vision | NME |
| 1999/6/9 | D01009 | H05BX03 | Doxercalciferol | Hectorol | Bone Care International | NME |
| 1999/5/25 | D00596 | A10BG02 | Rosiglitazone maleate | Avandia | SmithKline Beecham | NME |
| 1999/5/20 | D00568 | M01AH02 | Rofecoxib | Vioxx | Merck | NME |
| 1999/4/23 | D04028 | A08AB01 | Orlistat | Xenical | Hoffmann-La Roche | NME |
| 1999/4/15 | D00894 | J05AE05 | Amprenavir | Agenerase | Glaxo Wellcome | NME |
| 1999/2/18 | D05859 | Sodium ferric gluconate complex | Ferrlecit | R&D Lab | NME | |
| 1999/2/2 | D02815 | D11AH04 L01XF02 |
Alitretinoin | Panretin | Ligand Pharm | NME |
| 1999/1/15 | D01896 | B01AC23 | Cilostazol | Pletal | Otsuka Pharmaceutical | NME |
| Date | KEGG | ATC | Proper name | Tradename | Manufacturer | Remark |
| 2024/12/19 | D09719 | Remestemcel-L | Ryoncil | Mesoblast, Inc | BLA | |
| 2024/12/19 | Acellular tissue engineered vessel | Symvess | Humacyte Global, Inc | BLA | ||
| 2024/11/20 | Hematopoietic progenitor cell, cord blood | Regenecyte | StemCyte, Inc | |||
| 2024/11/13 | D12407 | A16AB26 | Eladocagene exuparvovec | KebiLidi | PTC Therapeutics | BLA |
| 2024/11/8 | D13022 | L01XL12 | Obecabtagene autoleucel | Aucatzyl | Autolus Limited | BLA |
| 2024/8/1 | D12951 | Afamitresgene autoleucel | Tecelra | Adaptimmune LLC | BLA | |
| 2024/4/25 | D12908 | (B02BD17) | Fidanacogene elaparvovec | Beqvez | Pfizer, Inc | BLA |
| 2024/3/18 | D12877 | Atidarsagene autotemcel | Lenmeldy | Orchard Therapeutics (Europe) Ltd | BLA | |
| 2024/2/16 | D12833 | L01XL11 | Lifileucel | Amtagvi | WuXi Advanced Therapeutics | BLA |
| 2023/12/8 | D12765 | (B06AX06) | Lovotibeglogene autotemcel | Lyfgenia | Bluebird Bio Inc | BLA |
| 2023/12/8 | D12749 | B06AX05 | Exagamglogene autotemcel | Casgevy | Vertex Pharmaceuticals Inc | BLA |
| 2023/6/30 | D12434 | B02BD15 | Valoctocogene roxaparvovec | Roctavian | BioMarin Pharmaceutical Inc | BLA |
| 2023/6/23 | D12634 | (A10XX02) | Donislecel | Lantidra | CellTrans Inc | BLA |
| 2023/6/22 | D12633 | M09AX15 | Delandistrogene moxeparvovec | Elevidys | Sarepta Therapeutics, Inc | BLA |
| 2023/5/13 | D12632 | D03AX16 | Beremagene geperpavec | Vyjuvek | Krystal Biotech, Inc | BLA |
| 2023/4/17 | D12592 | Omidubicel | Omisirge | Gamida Cell, Inc | BLA | |
| 2022/12/16 | D12531 | L01XL10 | Nadofaragene firadenovec | Adstiladrin | Ferring Pharmaceuticals | BLA |
| 2022/11/22 | D12500 | B02BD16 | Etranacogene dezaparvovec | Hemgenix | CSL Behring | BLA |
| 2022/9/16 | D12150 | A16AX21 | Elivaldogene autotemcel | Skysona | Bluebird bio Inc | BLA |
| 2022/8/17 | D11930 | B06AX02 | Betibeglogene autotemcel | Zynteglo | Bluebird bio Inc | BLA |
| 2022/2/28 | D12315 | L01XL05 | Ciltacabtagene autoleucel | Carvykti | Janssen Biotech, Inc | BLA |
| 2021/10/8 | Allogeneic processed thymus tissue–agdc | Rethymic | Enzyvant Therapeutics | |||
| 2021/6/15 | Allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen | Stratagraft | Stratatech Corporation | |||
| 2021/6/4 | D12149 | Plasminogen, human | Ryplazim | Prometic Bioproduction Inc | BLA | |
| 2021/3/26 | D11556 | L01XL07 | Idecabtagene vicleucel | Abecma | Celgene Corporation | BLA |
| 2021/2/5 | D11990 | L01XL08 | Lisocabtagene maraleucel | Breyanzi | Juno Therapeutics, Inc | BLA |
| 2020/7/24 | D11880 | L01XL06 | Brexucabtagene autoleucel | Tecartus | Kite Pharma | BLA |
| 2020/4/1 | D00172 | B02BD08 | Coagulation factor VIIa (recombinant) | Sevenfact | Laboratoire Francais du Fractionnement et des Biotechnologies S.A. | BLA |
| 2019/5/24 | D11559 | M09AX09 | Onasemnogene abeparvovec | Zolgensma | AveXis | BLA |
| 2018/6/21 | Hematopoietic progenitor cell, cord blood | MD Anderson Cord Blood Bank | ||||
| 2017/12/19 | D11008 | S01XA27 | Voretigene neparvovec | Luxturna | Spark Therapeutics | BLA |
| 2017/10/18 | D11144 | L01XL03 | Axicabtagene ciloleucel | Yescarta | Kite Pharma | BLA |
| 2017/8/30 | D11386 | L01XL04 | Tisagenlecleucel | Kymriah | Novartis Pharmaceuticals | BLA |
| 2016/12/13 | Autologous cultured chondrocytes on a porcine collagen membrane | Maci | Vericel Corporation | |||
| 2016/9/1 | Hematopoietic progenitor cell, cord blood | Clevecord | Cleveland Cord Blood Center | |||
| 2016/1/28 | Hematopoietic progenitor cell, cord blood | Bloodworks | ||||
| 2015/10/27 | D09966 | L01XL02 | Talimogene laherparepvec | Imlygic | Amgen | BLA |
| 2013/6/13 | Hematopoietic progenitor cell, cord blood | LifeSouth Community Blood Centers | ||||
| 2013/5/30 | Hematopoietic progenitor cell, cord blood | Allocord | SSM Cardinal Glennon Children's Medical Center | |||
| 2012/10/4 | Hematopoietic progenitor cell, cord blood | Ducord | Duke University School of Medicine | |||
| 2012/5/24 | Hematopoietic progenitor cell, cord blood | Clinimmune Labs, University of Colorado Cord Blood Bank | ||||
| 2012/3/9 | Allogeneic cultured keratinocytes and fibroblasts in bovine collagen | Gintuit | Organogenesis Incorporated | |||
| 2011/11/10 | Hematopoietic progenitor cell, cord blood | Hemacord | New York Blood Center | |||
| 2011/6/21 | D10057 | Azficel-T | Laviv | Fibrocell Technologies | BLA | |
| 2010/4/29 | D06644 | L03AX17 | Sipuleucel-T | Provenge | Dendreon Corporation | BLA |
| Date | KEGG | ATC | Proper name | Tradename | Manufacturer | Remark |
| 2023/4/26 | Fecal microbiota spores, live | Vowst | Seres Therapeutics, Inc | BLA | ||
| 2022/11/30 | Fecal microbiota, live | Rebyota | Ferring Pharmaceuticals | BLA |